https://pharmadispatch.com/news/cabinet-documents-from-the-year-that-led-to-transformational-changes 2026-01-01T23:32:01+11:00 https://pharmadispatch.com/news/adalta-and-shcell-launch-cancer-collaboration-to-progress-breakthrough-car-t-therapy 2026-01-03T00:11:01+11:00 https://pharmadispatch.com/news/reform-was-justified-because-a-committee-prioritising-clinical-considerationswas-culturally-prob 2026-01-04T23:07:01+11:00 https://pharmadispatch.com/news/vaxxas-appoints-former-global-vaccines-leader-to-head-global-commercialisation-push 2026-01-08T22:44:01+11:00 https://pharmadispatch.com/news/the-value-of-looking-back-and-the-importance-of-seeing-the-smoke-signals-on-reform 2026-01-08T23:32:01+11:00 https://pharmadispatch.com/news/new-treatment-listed-on-pbs-offering-twice-yearly-dosing-for-australians-with-relapsing-ms 2026-01-09T23:42:01+11:00 https://pharmadispatch.com/news/reading-between-the-reform-lines-what-the-2005-cabinet-papers-can-teach-us-today 2026-01-12T04:58:01+11:00 https://pharmadispatch.com/news/johnson-johnson-the-latest-to-sign-most-favored-nation-agreement-with-trump-administration 2026-01-12T06:13:01+11:00 https://pharmadispatch.com/news/a-good-to-reread-this-document-even-its-redactions-reveal-that-change-might-be-coming 2026-01-14T02:26:01+11:00 https://pharmadispatch.com/news/ausbiotech-joins-trade-diversification-network-to-boost-global-life-sciences-partnerships 2026-01-14T03:59:01+11:00 https://pharmadispatch.com/news/anne-harris-steps-down-after-defining-leadership-during-covid-and-lasting-impact-on-medicines-au 2026-01-15T04:45:01+11:00 https://pharmadispatch.com/news/abbvie-to-consolidate-sydney-operations-with-move-to-cbd-headquarters 2026-01-16T03:29:01+11:00 https://pharmadispatch.com/news/the-quiet-and-steady-privatisation-of-this-critical-public-health-program 2026-01-18T21:19:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-again-recognised-as-a-top-employer-across-australia-and-new-zealand 2026-01-19T02:05:01+11:00 https://pharmadispatch.com/news/prescription-medicines-at-the-centre-of-trumps-great-healthcare-plan 2026-01-19T02:17:01+11:00 https://pharmadispatch.com/news/australians-pay-more-out-of-pocket-for-medicines-than-many-comparable-countries 2026-01-19T21:46:01+11:00 https://pharmadispatch.com/news/a-universal-program-that-creates-an-unequal-burden-for-the-average-family 2026-01-19T22:19:01+11:00 https://pharmadispatch.com/news/immuron-delivers-continued-sales-growth-across-key-global-markets 2026-01-20T00:07:01+11:00 https://pharmadispatch.com/news/zelira-secures-transformative-funding-to-advance-hope-1-autism-program 2026-01-20T00:14:01+11:00 https://pharmadispatch.com/news/sanofi-starts-new-chapter-with-the-opening-of-barangaroo-headquarters 2026-01-20T01:04:01+11:00 https://pharmadispatch.com/news/the-pbs-paradox-a-rising-medicine-spend-but-a-shrinking-investment-capacity 2026-01-20T23:13:01+11:00 https://pharmadispatch.com/news/new-zealands-pharmac-plots-a-cautious-path-on-weight-loss-therapies 2026-01-20T23:31:01+11:00 https://pharmadispatch.com/news/industry-says-opportunity-cost-isnt-the-whole-story-in-nices-threshold-debate 2026-01-21T01:17:01+11:00 https://pharmadispatch.com/news/equipping-life-sciences-leaders-to-manage-foreign-interference-risks 2026-01-21T21:36:01+11:00 https://pharmadispatch.com/news/noxopharm-completes-heracles-trial-with-positive-safety-outcome-for-sof-skn 2026-01-21T21:49:01+11:00 https://pharmadispatch.com/news/telix-delivers-on-2025-revenue-targets-as-gozellix-fuels-next-phase-of-growth 2026-01-21T21:54:01+11:00 https://pharmadispatch.com/news/the-opportunity-for-advocacy-to-shift-from-marginal-reform-to-structural-sustainability 2026-01-21T23:28:01+11:00 https://pharmadispatch.com/news/new-data-reinforce-promise-of-cancer-vaccine-with-australia-playing-a-key-role 2026-01-22T04:40:01+11:00 https://pharmadispatch.com/news/argenx-deepens-australian-research-footprint-with-monash-partnership 2026-01-22T05:37:01+11:00 https://pharmadispatch.com/news/for-almost-all-of-the-last-40-years-governments-have-aimed-to-make-medicines-less-affordable 2026-01-22T21:22:01+11:00 https://pharmadispatch.com/news/new-funding-deal-brings-next-generation-cystic-fibrosis-treatments-closer-for-new-zealanders 2026-01-22T23:29:01+11:00 https://pharmadispatch.com/news/specialised-therapeutics-brings-new-hope-to-women-with-her2-positive-breast-cancer-in-thailand 2026-01-23T03:33:01+11:00 https://pharmadispatch.com/news/ausbiotech-announces-new-advisory-groups-to-support-the-life-sciences-sector 2026-01-23T03:41:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-episode-1-series-5 2026-01-24T00:36:01+11:00 https://pharmadispatch.com/news/this-regulatory-restriction-is-too-harmful-to-be-described-as-simply-outdated 2026-01-25T21:57:01+11:00 https://pharmadispatch.com/news/leading-pharmacists-honoured-in-2026-australia-day-awards 2026-01-26T22:11:01+11:00 https://pharmadispatch.com/news/strong-us-debut-for-novo-nordisk-pill-signals-potential-shift-in-global-weight-loss-market 2026-01-26T22:18:01+11:00 https://pharmadispatch.com/news/australias-health-information-ecosystem-is-very-full-but-do-the-best-voices-dominate 2026-01-27T23:13:01+11:00 https://pharmadispatch.com/news/americans-pay-a-much-lower-share-of-health-costs-than-we-do-in-australia 2026-01-28T00:21:01+11:00 https://pharmadispatch.com/news/uk-life-sciences-report-highlights-pressures-familiar-to-australian-industry 2026-01-28T01:38:01+11:00 https://pharmadispatch.com/news/trump-administration-launches-third-round-of-price-negotiations-including-the-first-renegotiatio 2026-01-28T21:24:01+11:00 https://pharmadispatch.com/news/patrys-completes-reliis-acquisition-expands-clinical-pipeline-and-strengthens-board 2026-01-28T21:51:01+11:00 https://pharmadispatch.com/news/obesity-medicines-the-limits-of-the-pbs-and-the-test-of-policy-imagination 2026-01-28T22:56:01+11:00 https://pharmadispatch.com/news/peer-reviewed-validation-strengthens-paradigms-osteoarthritis-program 2026-01-28T23:59:01+11:00 https://pharmadispatch.com/news/new-digital-health-reforms-to-give-australians-a-more-complete-medicines-history 2026-01-29T00:18:01+11:00 https://pharmadispatch.com/news/why-do-some-appear-so-uncomfortable-with-this-group-of-people-getting-help 2026-01-29T23:29:01+11:00 https://pharmadispatch.com/news/astrazeneca-appoints-new-country-president-as-ben-mcdonald-transitions-to-global-role 2026-01-30T00:09:01+11:00 https://pharmadispatch.com/news/arcs-warns-workforce-gaps-threaten-returns-on-clinical-trials-reform 2026-01-30T02:33:01+11:00 https://pharmadispatch.com/news/how-an-australian-campaign-is-tackling-the-silent-epidemic-of-heart-and-kidney-disease 2026-01-30T05:11:01+11:00 https://pharmadispatch.com/news/international-hta-collaboration-continues-as-global-pricing-pressures-evolve 2026-01-30T05:23:01+11:00 https://pharmadispatch.com/news/new-long-term-data-suggest-sustained-benefit-of-eisai-therapy-in-early-alzheimers-disease 2026-01-31T00:57:01+11:00 https://pharmadispatch.com/news/amgen-announces-leadership-transition-for-australia-and-new-zealand 2026-01-31T00:57:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-episode-2-series-5 2026-01-31T04:31:01+11:00 https://pharmadispatch.com/news/vertex-announces-pbs-listing-of-new-once-daily-treatment-for-cystic-fibrosis 2026-02-01T22:04:01+11:00 https://pharmadispatch.com/news/pfizer-calls-for-budget-shift-citing-missed-medicines-and-the-impact-of-lost-productivity 2026-02-01T22:16:01+11:00 https://pharmadispatch.com/news/better-access-australias-plan-to-make-care-fair-affordable-and-accountable 2026-02-01T22:51:01+11:00 https://pharmadispatch.com/news/an-announcement-that-cost-more-than-the-listing-because-it-would-have-actually-cost-something 2026-02-02T02:39:01+11:00 https://pharmadispatch.com/news/another-potential-turning-point-for-immunotherapy-access-in-australia 2026-02-02T02:54:01+11:00 https://pharmadispatch.com/news/recce-pharmaceuticals-deepens-us-partnership-to-advance-burn-wound-treatment 2026-02-02T20:30:01+11:00 https://pharmadispatch.com/news/ema-decision-clears-regulatory-path-for-argenicas-lead-stroke-drug-in-europe 2026-02-02T20:35:01+11:00 https://pharmadispatch.com/news/genetic-signatures-appoints-seasoned-life-sciences-executive-as-ceo 2026-02-02T20:42:01+11:00 https://pharmadispatch.com/news/pycs-capital-raise-marks-one-of-the-largest-biotech-fundraisings-in-australian-market-history 2026-02-02T21:21:01+11:00 https://pharmadispatch.com/news/sandoz-adds-to-vision-care-options-with-the-listing-of-biosimilar-aflibercept 2026-02-02T22:47:01+11:00 https://pharmadispatch.com/news/cyclopharm-delivers-record-revenue-as-us-emerges-as-growth-engine 2026-02-03T01:05:01+11:00 https://pharmadispatch.com/news/ausbiotech-urges-adoption-national-life-sciences-strategy-as-global-competition-intensifies 2026-02-03T02:05:01+11:00 https://pharmadispatch.com/news/arthritis-australia-appoints-louise-hardy-as-ceo-at-pivotal-moment-for-national-advocacy 2026-02-03T04:46:01+11:00 https://pharmadispatch.com/news/if-youre-going-to-pay-for-reforms-are-these-the-changes-you-want-pay-for 2026-02-03T20:41:01+11:00 https://pharmadispatch.com/news/ausbiotech-and-medicines-australia-unite-to-accelerate-advanced-therapies 2026-02-04T01:25:01+11:00 https://pharmadispatch.com/news/juvenile-arthritis-foundation-australia-seeks-new-ceo-as-angela-mckay-steps-down 2026-02-04T01:28:01+11:00 https://pharmadispatch.com/news/survey-exposes-deep-gaps-in-support-for-australians-living-with-rare-cancers 2026-02-04T02:09:01+11:00 https://pharmadispatch.com/news/medicines-australia-calls-for-budget-action-to-restore-access-to-innovative-medicines 2026-02-04T04:18:01+11:00 https://pharmadispatch.com/news/gbma-moves-to-reclaim-the-reform-agenda-with-a-focus-on-pricing-and-supply 2026-02-05T13:00:01+11:00 https://pharmadispatch.com/news/gbma-summit-focuses-on-access-affordability-and-security-in-an-uncertain-world 2026-02-05T00:28:01+11:00 https://pharmadispatch.com/news/pfizers-once-monthly-weight-loss-injection-delivers-strong-mid-stage-results 2026-02-05T01:02:01+11:00 https://pharmadispatch.com/news/nuclear-medicine-sector-argues-for-dedicated-scheme-to-unlock-cancer-therapies 2026-02-05T02:04:01+11:00 https://pharmadispatch.com/news/pharmac-consults-on-expanding-access-to-takeda-blood-cancer-therapy 2026-02-06T00:11:01+11:00 https://pharmadispatch.com/news/an-effective-example-of-making-the-case-for-reform-in-a-status-quo-biased-system 2026-02-06T01:28:01+11:00 https://pharmadispatch.com/news/ai-in-healthcare-and-why-doing-nothing-might-be-the-biggest-risk 2026-02-06T03:03:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-6-february 2026-02-07T01:16:01+11:00 https://pharmadispatch.com/news/queensland-launches-largest-free-flu-vaccination-program-in-australia 2026-02-07T01:19:01+11:00 https://pharmadispatch.com/news/why-australian-men-are-turning-to-their-pharmacies-for-healthcare 2026-02-07T01:19:01+11:00 https://pharmadispatch.com/news/trumprx-launches-based-on-global-pricing-promise-in-an-insurance-dominated-reality 2026-02-08T00:09:01+11:00 https://pharmadispatch.com/news/the-leaders-will-be-thinking-about-this-situation-like-a-game-of-chess 2026-02-08T03:17:01+11:00 https://pharmadispatch.com/news/the-race-for-the-pharma-cup-heats-up-as-teams-chase-the-summit 2026-02-09T01:37:01+11:00 https://pharmadispatch.com/news/a-new-option-for-kiwis-with-lilly-confirming-mounjaro-launch-in-new-zealand 2026-02-09T22:46:01+11:00 https://pharmadispatch.com/news/womens-health-reforms-deliver-savings-and-expanded-access-one-year-on 2026-02-09T23:01:01+11:00 https://pharmadispatch.com/news/meeting-of-the-minds-and-the-impact-of-not-being-able-to-unknow-information 2026-02-10T00:59:01+11:00 https://pharmadispatch.com/news/positive-action-grants-invest-200000-in-community-driven-hiv-initiatives-across-australia 2026-02-10T03:22:01+11:00 https://pharmadispatch.com/news/mfn-is-the-name-but-the-real-consequences-will-be-delivered-through-globe-and-guard 2026-02-10T21:00:01+11:00 https://pharmadispatch.com/news/a-simple-increase-in-published-list-prices-could-have-unintended-consequences 2026-02-11T00:24:01+11:00 https://pharmadispatch.com/news/can-we-keep-avoiding-the-simplest-of-all-question-in-a-new-global-order 2026-02-11T01:15:01+11:00 https://pharmadispatch.com/news/molecule2market-appoints-inaugural-ceo-to-lead-next-phase-of-growth 2026-02-11T02:22:01+11:00 https://pharmadispatch.com/news/immutep-reaches-midpoint-in-global-phase-3-lung-cancer-trial 2026-02-11T02:24:01+11:00 https://pharmadispatch.com/news/algorae-expands-commercial-footprint-with-new-licensing-deal 2026-02-11T02:26:01+11:00 https://pharmadispatch.com/news/memphasys-fast-tracks-australian-market-entry-with-early-tga-approval-for-felix-system 2026-02-11T02:27:01+11:00 https://pharmadispatch.com/news/bcec-partners-with-life-sciences-queensland-to-launch-bursary-for-next-gen-bio-innovation-leader 2026-02-11T02:29:01+11:00 https://pharmadispatch.com/news/tiny-fragments-of-rna-a-giant-opportunity-for-autoimmune-disease-treatment 2026-02-11T02:34:01+11:00 https://pharmadispatch.com/news/csl-signals-leadership-transition-as-paul-mckenzie-retires-and-gordon-naylor-steps-in-as-interim 2026-02-11T03:14:01+11:00 https://pharmadispatch.com/news/this-might-be-the-real-once-in-a-generation-opportunity-achieve-reform 2026-02-12T00:36:01+11:00 https://pharmadispatch.com/news/csl-presses-ahead-with-transformation-as-earnings-slip-and-leadership-changes 2026-02-12T01:06:01+11:00 https://pharmadispatch.com/news/canine-osteoarthritis-study-offers-compelling-translational-evidence-for-pps 2026-02-12T01:46:01+11:00 https://pharmadispatch.com/news/amplia-expands-us-footprint-as-amplicity-pancreatic-cancer-trial-gains-momentum 2026-02-12T01:58:01+11:00 https://pharmadispatch.com/news/arrotex-and-pfizer-forge-strategic-pharmacy-partnership-for-enbrel-in-australia 2026-02-12T02:09:01+11:00 https://pharmadispatch.com/news/there-is-no-negotiation-yet-so-be-careful-not-to-give-the-impression-of-conceding-anything 2026-02-12T02:31:01+11:00 https://pharmadispatch.com/news/ten-years-of-process-improvements-is-almost-the-point-says-anne-ruston 2026-02-13T13:07:01+11:00 https://pharmadispatch.com/news/senate-scrutiny-of-pbs-rules-after-canberra-family-highlights-lack-of-biologic-access 2026-02-13T04:39:01+11:00 https://pharmadispatch.com/news/pbac-to-reconsider-broader-vaccine-funding-after-late-addition-to-march-agenda 2026-02-13T15:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-13-february 2026-02-14T02:37:01+11:00 https://pharmadispatch.com/news/australian-medtech-secures-funds-to-advance-real-time-breast-cancer-surgery-technology 2026-02-14T03:08:01+11:00 https://pharmadispatch.com/news/sussan-leys-sometimes-contentious-but-unquesionably-consequential-health-legacy 2026-02-15T20:11:01+11:00 https://pharmadispatch.com/news/pbs-spending-is-driven-less-by-explicit-fiscal-choices-and-more-by-the-flow-of-recommendations 2026-02-15T20:28:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-sets-sights-on-2026-kosi-challenge-with-renewed-fundraising-momentum 2026-02-16T00:11:01+11:00 https://pharmadispatch.com/news/its-the-first-time-in-over-30-years-that-a-new-way-of-administering-adrenaline-has-been-approved 2026-02-16T20:18:01+11:00 https://pharmadispatch.com/news/chimeric-therapeutics-names-experienced-biotech-leader-as-chair-in-board-and-executive-refresh 2026-02-16T21:13:01+11:00 https://pharmadispatch.com/news/imf-pours-cold-water-on-fears-of-us-pharmaceutical-tariffs-as-pressures-shift-to-care-spending 2026-02-16T21:44:01+11:00 https://pharmadispatch.com/news/medibank-funding-expansion-signals-momentum-for-emyrias-mental-health-model 2026-02-16T22:12:01+11:00 https://pharmadispatch.com/news/new-imaging-agent-shows-stronger-detection-of-recurrent-prostate-cancer-in-head-to-head-trial 2026-02-16T22:30:01+11:00 https://pharmadispatch.com/news/life-sciences-sector-unites-to-advance-womens-leadership-at-landmark-2026-events 2026-02-17T00:50:01+11:00 https://pharmadispatch.com/news/director-pay-rises-across-asx-healthcare-sector-but-gender-balance-remains-uneven 2026-02-17T01:13:01+11:00 https://pharmadispatch.com/news/minister-confirms-pbs-listing-for-new-cystic-fibrosis-therapy-and-funded-access-to-other-medicin 2026-02-17T02:41:01+11:00 https://pharmadispatch.com/news/taylor-confirms-anne-ruston-to-retain-health-and-disability-portfolio-in-opposition-reshuffle 2026-02-18T03:00:01+11:00 https://pharmadispatch.com/news/phrma-targets-the-pbs-urges-priority-watch-list-inclusion-over-policy-failings 2026-02-17T22:02:01+11:00 https://pharmadispatch.com/news/in-this-system-one-group-of-patients-is-more-or-less-deserving-than-another-and-its-wrong 2026-02-17T22:25:01+11:00 https://pharmadispatch.com/news/calls-grow-for-national-response-to-australias-worsening-medicine-shortages 2026-02-18T01:06:01+11:00 https://pharmadispatch.com/news/urgent-action-needed-as-antibiotic-resistance-threatens-australias-health-future 2026-02-18T04:15:01+11:00 https://pharmadispatch.com/news/percheron-targets-next-wave-of-immunotherapy-with-novel-vista-checkpoint-candidate 2026-02-18T20:09:01+11:00 https://pharmadispatch.com/news/targeted-blood-cancer-treatments-proposed-for-funding-in-new-zealand 2026-02-18T22:46:01+11:00 https://pharmadispatch.com/news/csl-and-lilly-strike-strategic-deal-to-advance-promising-anti-inflammatory-therapy 2026-02-18T22:51:01+11:00 https://pharmadispatch.com/news/novo-nordisk-backs-community-led-initiative-that-aims-to-transform-life-for-logans-children 2026-02-19T01:14:01+11:00 https://pharmadispatch.com/news/ausbiotechproto-axiom-alliance-aims-to-fast-track-australias-next-wave-of-biotech-innovators 2026-02-19T01:22:01+11:00 https://pharmadispatch.com/news/nyrada-advances-lead-candidate-into-mid-stage-trial-as-mmomentum-builds-across-programs 2026-02-19T01:45:01+11:00 https://pharmadispatch.com/news/idt-signals-turnaround-as-revenue-rises-and-losses-narrow-under-strategic-reset 2026-02-19T01:52:01+11:00 https://pharmadispatch.com/news/telix-files-for-european-approval-of-brain-cancer-imaging-candidate-tlx101-px 2026-02-19T01:59:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-emerges-as-growth-engine-after-delivering-strong-first-half 2026-02-19T21:44:01+11:00 https://pharmadispatch.com/news/why-does-anyone-accept-a-review-outcome-that-simply-affirms-a-settled-order 2026-02-19T22:46:01+11:00 https://pharmadispatch.com/news/phrma-launches-new-campaign-against-the-backdrop-of-a-more-assertive-us 2026-02-20T02:46:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-20-february 2026-02-20T23:16:01+11:00 https://pharmadispatch.com/news/australian-biotech-leader-highlights-the-car-t-access-challenge-for-local-industry 2026-02-21T23:35:01+11:00 https://pharmadispatch.com/news/the-two-sides-of-decision-making-compassion-and-calculation-in-funding-outcomes 2026-02-22T21:58:01+11:00 https://pharmadispatch.com/news/tariff-ruling-unlikely-to-reverse-industry-shift-toward-us-investment-and-global-pricing-shift 2026-02-22T23:45:01+11:00 https://pharmadispatch.com/news/rare-cancers-australia-kosi-challenge-builds-momentum-ahead-of-march-climb 2026-02-23T00:15:01+11:00 https://pharmadispatch.com/news/mayne-pharma-enters-a-new-phase-as-leadership-transition-coincides-with-resilient-first-half-per 2026-02-23T21:36:01+11:00 https://pharmadispatch.com/news/argent-biopharma-reaches-milestone-as-major-cannepil-shipment-lands-in-ireland 2026-02-23T21:50:01+11:00 https://pharmadispatch.com/news/pharmx-and-sigma-announce-alliance-aiming-to-strengthen-pharmacy-supply-chains-across-anz 2026-02-23T22:04:01+11:00 https://pharmadispatch.com/news/mtpconnect-launches-new-funding-push-to-fast-track-breakthroughs-in-heart-disease-and-diabetes 2026-02-23T22:21:01+11:00 https://pharmadispatch.com/news/research-australia-calls-for-investment-to-drive-productivity-agenda 2026-02-23T23:35:01+11:00 https://pharmadispatch.com/news/australia-can-demand-tariff-relief-but-unfinished-fta-promises-weaken-its-case 2026-02-24T00:38:01+11:00 https://pharmadispatch.com/news/formosa-and-arrotex-forge-strategic-partnership-to-expand-access-to-innovative-eye-treatment 2026-02-24T16:28:01+11:00 https://pharmadispatch.com/news/this-kind-of-project-doesnt-ask-for-permission-it-just-creates-pressure-for-change 2026-02-25T03:11:01+11:00 https://pharmadispatch.com/news/omico-precision-oncology-model-delivering-as-it-seeks-new-funding-to-secure-future 2026-02-25T03:36:01+11:00 https://pharmadispatch.com/news/patients-the-priority-as-takeda-australia-reflects-on-purpose-during-patient-week-2026 2026-02-25T06:02:01+11:00 https://pharmadispatch.com/news/grnenthal-partners-with-clinect-to-bring-non-opioid-pain-patch-to-australia 2026-02-25T06:09:01+11:00 https://pharmadispatch.com/news/ebos-builds-momentum-as-glp-1-therapy-wave-reshapes-the-healthcare-market 2026-02-25T21:22:01+11:00 https://pharmadispatch.com/news/blood-test-discovery-may-help-predict-head-and-neck-cancer-relapse-risk 2026-02-25T21:55:01+11:00 https://pharmadispatch.com/news/immutep-strengthens-focus-on-late-stage-immunotherapy-trial-as-pipeline-momentum-builds 2026-02-25T22:03:01+11:00 https://pharmadispatch.com/news/acrux-returns-to-profit-as-product-launches-and-strategic-reset-drive-revenue-growth 2026-02-25T22:16:01+11:00 https://pharmadispatch.com/news/neurizon-advances-als-drug-program-as-funding-trials-and-global-partnerships-gain-momentum 2026-02-25T22:25:01+11:00 https://pharmadispatch.com/news/weight-loss-medicines-approved-in-new-zealand-and-recommended-for-funding-but-pathway-remains-un 2026-02-25T22:55:01+11:00 https://pharmadispatch.com/news/reading-the-room-on-reform-might-mean-following-the-budget-message 2026-02-26T05:22:01+11:00 https://pharmadispatch.com/news/there-are-in-effect-two-pharmaceutical-benefits-schemes-operating-in-australia-today 2026-02-26T20:44:01+11:00 https://pharmadispatch.com/news/united-front-forms-across-asia-pacific-to-change-the-future-of-pulmonary-arterial-hypertension 2026-02-26T22:32:01+11:00 https://pharmadispatch.com/news/eu-backs-australian-led-consortium-with-up-to-250m-to-advance-next-generation-influenza-vaccines 2026-02-27T05:33:01+11:00 https://pharmadispatch.com/news/senate-committee-backs-reform-to-enable-nurse-prescribing-under-the-pbs 2026-02-27T20:42:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-27-february 2026-02-27T22:59:01+11:00 https://pharmadispatch.com/news/landmark-trial-pits-next-generation-glp-1-pills-head-to-head-in-type-2-diabetes 2026-02-27T23:07:01+11:00 https://pharmadispatch.com/news/a-claim-and-a-report-that-continue-to-be-consistently-misrepresented 2026-02-28T21:06:01+11:00 https://pharmadispatch.com/news/pbs-listing-expands-access-to-immunotherapy-for-australians-with-advanced-cancer 2026-03-01T21:05:01+11:00 https://pharmadispatch.com/news/the-nine-year-wait-should-raise-some-important-but-uncomfortable-questions 2026-03-01T21:19:01+11:00 https://pharmadispatch.com/news/pbs-listings-gives-new-hope-for-people-living-with-rare-autoimmune-disease 2026-03-02T02:14:01+11:00 https://pharmadispatch.com/news/when-work-can-get-in-the-way-of-care-for-endometriosis 2026-03-02T02:20:01+11:00 https://pharmadispatch.com/news/australia-counts-the-massive-cost-of-obesity-as-new-report-warns-of-a-growing-economic-crisis 2026-03-02T22:52:01+11:00 https://pharmadispatch.com/news/healthsave-reaches-100-store-milestone-as-pharmacy-network-accelerates-national-growth 2026-03-02T23:19:01+11:00 https://pharmadispatch.com/news/new-hope-for-australians-with-aggressive-lymphoma-as-roche-therapy-secures-pbs-listing 2026-03-02T23:30:01+11:00 https://pharmadispatch.com/news/criminals-and-migrants-have-formal-rights-of-appeal-but-not-australian-patients-why 2026-03-03T00:50:01+11:00 https://pharmadispatch.com/news/slade-pharmacy-expands-partnership-with-st-john-of-god-health-care-across-eleven-hospitals 2026-03-03T04:16:01+11:00 https://pharmadispatch.com/news/genetic-breakthrough-brings-new-hope-for-australians-living-with-multiple-sclerosis 2026-03-03T22:58:01+11:00 https://pharmadispatch.com/news/pharma-teams-surge-past-220000-in-2026-rare-cancers-australia-kosi-challenge 2026-03-03T23:17:01+11:00 https://pharmadispatch.com/news/fda-approved-new-cancer-therapy-and-ensures-patient-access-in-just-44-days 2026-03-04T01:37:01+11:00 https://pharmadispatch.com/news/new-report-says-faster-and-fairer-access-to-medicines-within-reach-for-new-zealand 2026-03-04T03:22:01+11:00 https://pharmadispatch.com/news/australian-medtech-innovators-move-closer-to-procurement-through-national-capability-program 2026-03-04T22:19:01+11:00 https://pharmadispatch.com/news/alterity-strengthens-clinical-leadership-with-appointment-of-neurologist-daniel-claassen 2026-03-04T22:25:01+11:00 https://pharmadispatch.com/news/pyc-therapeutics-secures-strong-backing-as-retail-offer-adds-47-million-to-capital-raise 2026-03-04T22:31:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-deepens-us-biodefence-ties-to-advance-marburg-treatment 2026-03-04T22:36:01+11:00 https://pharmadispatch.com/news/adalta-strengthens-clinical-push-for-breakthrough-solid-cancer-therapy 2026-03-04T22:47:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-targets-breakout-year-in-2026-as-nasodine-expansion-accelerates 2026-03-04T23:08:01+11:00 https://pharmadispatch.com/news/australia-at-a-crossroads-as-the-nuclear-medicine-revolution-gathers-pace 2026-03-12T13:00:01+11:00 https://pharmadispatch.com/news/a-system-built-for-a-past-is-struggling-to-meets-the-challenge-of-today-let-alone-the-future 2026-03-05T00:20:01+11:00 https://pharmadispatch.com/news/setting-the-standard-for-safe-and-accountable-virtual-healthcare-in-australia 2026-03-05T05:38:01+11:00 https://pharmadispatch.com/news/the-myth-of-affordability-australias-medicines-debate-is-really-about-choice 2026-03-05T20:09:01+11:00 https://pharmadispatch.com/news/csl-seqirus-to-supply-canada-with-pandemic-influenza-vaccines-from-new-melbourne-facility 2026-03-05T20:46:01+11:00 https://pharmadispatch.com/news/pfizer-and-abbvie-recognised-among-australias-best-workplaces-for-women 2026-03-05T21:12:01+11:00 https://pharmadispatch.com/news/wesfarmers-health-expands-medicine-access-with-major-new-cairns-fulfilment-centre 2026-03-05T21:26:01+11:00 https://pharmadispatch.com/news/pharma-teams-power-kosi-challenge-toward-500000-fundraising-milestone 2026-03-05T21:55:01+11:00 https://pharmadispatch.com/news/life-sciences-leaders-gather-in-sydney-to-advance-womens-leadership-on-international-womens-day 2026-03-06T02:20:01+11:00 https://pharmadispatch.com/news/bpdinsightsai-has-arrived-as-a-new-way-to-access-knowledge 2026-03-09T12:00:01+11:00 https://pharmadispatch.com/news/how-to-use-bpdinsightsai-to-learn-and-to-train-the-platform 2026-03-09T12:00:01+11:00 https://pharmadispatch.com/news/nanosonics-achieves-key-fda-clearance-as-coris-endoscope-coverage-expands 2026-03-09T20:42:01+11:00 https://pharmadispatch.com/news/labors-foi-backdown-is-a-welcome-victory-for-transparency-and-accountability 2026-03-10T14:00:01+11:00 https://pharmadispatch.com/news/lateral-pharma-secures-key-us-patent-for-novel-neuropathic-pain-therapy 2026-03-09T21:11:01+11:00 https://pharmadispatch.com/news/mark-butler-steps-in-to-block-eye-injection-funding-change-after-patient-warnings 2026-03-10T14:00:01+11:00 https://pharmadispatch.com/news/pharmac-says-new-agreement-has-improved-access-to-treatment-for-new-zealanders 2026-03-10T14:00:01+11:00 https://pharmadispatch.com/news/new-cancer-research-highlights-potential-of-narmafotinib-to-koost-kras-inhibitor-therapies 2026-03-10T03:19:01+11:00 https://pharmadispatch.com/news/island-pharmaceuticals-expands-antiviral-program-through-burnet-institute-collaboration 2026-03-10T03:26:01+11:00 https://pharmadispatch.com/news/there-is-an-ideology-behind-our-funding-systems-and-its-the-greatest-barrier-to-change 2026-03-11T13:00:01+11:00 https://pharmadispatch.com/news/csl-expands-us-manufacturing-with-15bn-investment-to-boost-plasma-therapy-production 2026-03-10T22:19:01+11:00 https://pharmadispatch.com/news/self-injection-option-offers-new-flexibility-for-australians-living-with-myasthenia-gravis 2026-03-10T22:30:01+11:00 https://pharmadispatch.com/news/new-digital-partnership-expands-access-to-vital-clinical-guidance-for-australian-healthcare-prof 2026-03-10T23:34:01+11:00 https://pharmadispatch.com/news/new-leader-appointed-to-drive-landmark-sydney-biomedical-hub-toward-global-health-breakthroughs 2026-03-11T01:10:01+11:00 https://pharmadispatch.com/news/new-patient-led-tool-launched-in-canberra-to-transform-pain-communication 2026-03-11T02:15:01+11:00 https://pharmadispatch.com/news/heidi-and-medadvisor-join-forces-to-bring-ai-powered-clinical-tools-to-australian-pharmacies 2026-03-12T01:29:01+11:00 https://pharmadispatch.com/news/fundraising-racing-towards-total-target-as-teams-and-participants-prepare-to-climb 2026-03-12T06:05:01+11:00 https://pharmadispatch.com/news/new-zealand-confirms-earlier-access-to-breakthrough-cystic-fibrosis-medicines 2026-03-12T13:00:01+11:00 https://pharmadispatch.com/news/australia-has-spent-four-decades-having-the-wrong-conversation-about-medicines-access 2026-03-13T13:00:01+11:00 https://pharmadispatch.com/news/an-absolute-medical-miracle-mps-highlight-progress-and-challenges-at-cystic-fibrosis-event 2026-03-13T13:00:01+11:00 https://pharmadispatch.com/news/the-leadership-challenge-behind-australias-medicine-access-gap 2026-03-13T13:01:01+11:00 https://pharmadispatch.com/news/australias-top-community-pharmacists-honoured-at-national-awards 2026-03-13T13:00:01+11:00 https://pharmadispatch.com/news/imugene-launches-20-million-capital-raise-to-fund-expansion-of-azer-cel-trials 2026-03-13T02:14:01+11:00 https://pharmadispatch.com/news/patrys-moves-toward-first-human-trial-for-injectable-delirium-therapy 2026-03-13T02:15:01+11:00 https://pharmadispatch.com/news/cell-therapy-company-mesoblast-names-executive-to-guide-clinical-development-and-medical-affairs 2026-03-13T02:16:01+11:00 https://pharmadispatch.com/news/a-new-prostate-cancer-technology-moves-closer-to-global-trials-after-strong-early-results 2026-03-13T02:17:01+11:00 https://pharmadispatch.com/news/sandoz-and-camp-quality-unite-to-strengthen-support-for-australian-families-facing-childhood-can 2026-03-13T15:00:01+11:00 https://pharmadispatch.com/news/australians-turn-to-local-pharmacies-as-frontline-of-everyday-healthcare 2026-03-13T22:44:01+11:00 https://pharmadispatch.com/news/new-program-aims-to-make-womens-health-care-more-affordable-and-accessible 2026-03-13T22:53:01+11:00 https://pharmadispatch.com/news/it-is-profoundly-wrong-for-any-system-to-exclude-compassion-while-outsourcing-it-to-others 2026-03-16T11:00:01+11:00 https://pharmadispatch.com/news/gsk-claims-pharma-cup-as-kosi-challenge-surpasses-fundraising-record 2026-03-16T00:28:01+11:00 https://pharmadispatch.com/news/csl-seqirus-adjuvanted-flu-vaccine-approval-extended-to-australians-aged-50-and-over 2026-03-16T02:56:01+11:00 https://pharmadispatch.com/news/scientists-identify-highly-specific-targets-that-could-transform-multiple-myeloma-treatment 2026-03-16T03:05:01+11:00 https://pharmadispatch.com/news/the-current-debate-over-pharmacy-prescribing-is-missing-a-key-fact 2026-03-16T21:07:01+11:00 https://pharmadispatch.com/news/new-survey-reveals-australians-still-misunderstand-multiple-sclerosis-despite-advances-in-treatm 2026-03-16T23:49:01+11:00 https://pharmadispatch.com/news/australian-pharmaceutical-partnership-aims-to-expand-access-to-innovative-hypertension-therapy 2026-03-17T00:18:01+11:00 https://pharmadispatch.com/news/royal-visit-highlights-new-collaborations-targeting-obesity-and-liver-disease 2026-03-17T00:22:01+11:00 https://pharmadispatch.com/news/the-moral-stakes-of-the-discussion-became-clear-and-then-hta-regains-control 2026-03-18T14:00:01+11:00 https://pharmadispatch.com/news/renewed-calls-for-major-investment-in-life-sciences-to-secure-nations-innovation-future 2026-03-18T13:00:01+11:00 https://pharmadispatch.com/news/advisory-committees-might-live-to-regret-their-increasing-role-as-policy-advisors 2026-03-18T13:00:01+11:00 https://pharmadispatch.com/news/implantable-sensor-approved-in-australia-could-transform-how-hydrocephalus-is-monitored 2026-03-18T02:32:01+11:00 https://pharmadispatch.com/news/regulators-clear-path-for-pivotal-trial-of-pyc-vision-therapy-for-rare-blinding-disease 2026-03-18T02:33:01+11:00 https://pharmadispatch.com/news/firebrick-pharma-recruits-global-dealmaker-to-accelerate-nasodine-expansion 2026-03-18T02:34:01+11:00 https://pharmadispatch.com/news/oncosil-secures-full-subscription-entitlement-offer-to-advance-cancer-treatment-program 2026-03-18T02:36:01+11:00 https://pharmadispatch.com/news/excellence-in-education-drives-a-stronger-pharmaceutical-industry 2026-03-17T13:00:01+11:00 https://pharmadispatch.com/news/owen-smith-on-the-missing-strategy-at-the-heart-of-australias-life-sciences-sector 2026-03-19T12:00:01+11:00 https://pharmadispatch.com/news/robyn-ward-calls-for-action-on-research-infrastructure-investment 2026-03-19T12:00:01+11:00 https://pharmadispatch.com/news/unified-voice-emerges-as-australias-medicinal-cannabis-leaders-join-forces 2026-03-19T02:11:01+11:00 https://pharmadispatch.com/news/australia-stakes-a-claim-in-global-gene-therapy-manufacturing-through-new-vvmf-and-oxb-partnersh 2026-03-19T05:47:01+11:00 https://pharmadispatch.com/news/australias-peculiar-obsession-with-hta-is-costing-jobs-and-lives 2026-03-20T13:00:01+11:00 https://pharmadispatch.com/news/integrated-alliance-aims-to-fast-track-theranostics-trials-in-australia 2026-03-20T12:00:01+11:00 https://pharmadispatch.com/news/sanofi-opens-new-headquarters-with-a-focus-on-community-and-innovation 2026-03-20T01:04:01+11:00 https://pharmadispatch.com/news/gilead-fellowships-mark-fifteen-years-of-advancing-australian-patient-care-research 2026-03-20T13:00:01+11:00 https://pharmadispatch.com/news/novo-noridisk-launches-program-aimed-at-turning-the-tide-on-medical-waste 2026-03-20T13:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-20-march 2026-03-20T23:55:01+11:00 https://pharmadispatch.com/news/balancing-price-speed-and-access-how-companies-manage-the-pathway-to-market-access 2026-03-23T13:00:01+11:00 https://pharmadispatch.com/news/the-importance-of-humility-and-understanding-the-other-side-of-the-equation 2026-03-22T13:00:01+11:00 https://pharmadispatch.com/news/pharmacy-guild-calls-for-tough-action-over-deeply-concerning-pbs-fraud 2026-03-23T13:00:01+11:00 https://pharmadispatch.com/news/pharmac-seeks-public-input-to-improve-understanding-of-complex-cases-program 2026-03-23T13:00:01+11:00 https://pharmadispatch.com/news/a-new-chapter-for-national-pharmacies-as-experienced-executive-steps-into-customer-leadership 2026-03-24T12:00:01+11:00 https://pharmadispatch.com/news/australian-biotech-surges-in-response-to-trial-suggesting-a-new-hope-in-the-fight-against-pancre 2026-03-24T12:00:01+11:00 https://pharmadispatch.com/news/pfizer-updates-on-promising-step-towards-a-lyme-disease-vaccine-candidate 2026-03-24T15:16:01+11:00 https://pharmadispatch.com/news/even-small-changes-can-still-become-foundations-for-the-next-but-understand-how-decisions-are-ma 2026-03-25T13:00:01+11:00 https://pharmadispatch.com/news/australia-moves-closer-to-europe-as-health-and-research-ties-deepen-under-landmark-agreement 2026-03-25T13:00:01+11:00 https://pharmadispatch.com/news/faster-fda-pathway-approves-new-higher-dose-weight-loss-therapy-in-just-54-days 2026-03-25T14:00:01+11:00 https://pharmadispatch.com/news/first-patient-treated-in-australian-trial-targeting-core-als-disease-mechanism 2026-03-25T02:28:01+11:00 https://pharmadispatch.com/news/cyclopharm-expands-us-footprint-with-major-multi-site-agreement-in-leading-academic-health-syste 2026-03-25T02:29:01+11:00 https://pharmadispatch.com/news/radiopharm-reports-strong-interim-results-for-brain-metastases-imaging-agent 2026-03-25T02:30:01+11:00 https://pharmadispatch.com/news/auditor-general-proposes-possible-reviews-of-new-centre-for-disease-control 2026-03-25T02:45:01+11:00 https://pharmadispatch.com/news/as-horizon-europe-winds-down-its-successor-program-remains-a-work-in-progress 2026-03-25T21:20:01+11:00 https://pharmadispatch.com/news/clarity-advances-us-manufacturing-strategy-with-major-copper-64-supply-agreement 2026-03-25T21:50:01+11:00 https://pharmadispatch.com/news/community-pharmacies-set-to-expand-patient-care-following-labor-re-election-in-south-australia 2026-03-26T00:28:01+11:00 https://pharmadispatch.com/news/pbac-agenda-reflects-increasing-number-of-companies-seeking-revised-recommendations 2026-03-26T01:37:01+11:00 https://pharmadispatch.com/news/to-what-extent-does-the-system-see-itself-as-bound-by-external-review 2026-03-26T02:04:01+11:00 https://pharmadispatch.com/news/budget-delivers-progress-but-hundreds-of-thousands-still-waiting-for-access 2026-03-26T03:53:01+11:00 https://pharmadispatch.com/news/liberty-expands-into-asia-pacific-life-sciences-insurance-with-new-tailored-offering 2026-03-26T04:43:01+11:00 https://pharmadispatch.com/news/this-is-the-not-so-quiet-demand-and-doctrine-of-rationed-health-care 2026-03-27T13:00:01+11:00 https://pharmadispatch.com/news/the-unseen-price-of-survival-for-women-facing-early-breast-cancer-in-australia 2026-03-27T13:00:01+11:00 https://pharmadispatch.com/news/if-these-can-be-presented-as-positives-then-we-really-have-become-accustomed-to-terrible 2026-03-27T02:25:01+11:00 https://pharmadispatch.com/news/breathing-easy-in-an-ageing-asia-pacific-means-fixing-a-neglected-health-crisis 2026-03-30T13:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-reviewpodcast-27-march 2026-03-27T22:29:01+11:00 https://pharmadispatch.com/news/government-expands-access-to-cancer-therapy-but-holds-short-on-pan-tumour-listing 2026-03-30T13:00:01+11:00 https://pharmadispatch.com/news/a-new-chapter-for-juvenile-arthritis-foundation-australia-as-it-continues-search-for-new-leaders 2026-03-28T02:58:01+11:00 https://pharmadispatch.com/news/new-treatment-milestone-offers-fresh-hope-for-australians-living-with-cidp 2026-03-30T13:00:01+11:00 https://pharmadispatch.com/news/open-letter-calls-for-ministerial-action-on-access-to-continuous-glucose-monitoring-devices 2026-03-30T13:00:01+11:00 https://pharmadispatch.com/news/the-minister-was-subtle-but-the-message-could-hardly-be-clearer 2026-03-30T20:52:01+11:00 https://pharmadispatch.com/news/a-silent-crisis-in-plain-sight-as-arthritis-burden-grows-while-research-funding-falls-behind 2026-03-31T13:00:01+11:00 https://pharmadispatch.com/news/a-new-opportunity-for-biosimilars-as-sector-leaders-gather-in-canberra 2026-03-31T13:00:01+11:00 https://pharmadispatch.com/news/those-who-recognise-and-respond-to-the-reality-will-be-better-positioned-to-shape-reforms 2026-03-31T13:00:01+11:00 https://pharmadispatch.com/news/ai-meets-oncology-as-algorae-advances-drug-discovery-collaboration 2026-03-30T23:02:01+11:00 https://pharmadispatch.com/news/cynata-reaches-crucial-milestone-as-phase-2-trial-moves-toward-results 2026-03-30T23:09:01+11:00 https://pharmadispatch.com/news/genetic-signatures-reshapes-its-business-to-cut-costs-and-drive-growth 2026-03-30T23:12:01+11:00 https://pharmadispatch.com/news/aroa-biosurgery-reports-promising-trial-milestone-for-advanced-wound-treatment 2026-03-30T23:17:01+11:00 https://pharmadispatch.com/news/alterity-therapeutics-updates-investors-on-key-meeting-with-us-regulator 2026-03-30T23:22:01+11:00 https://pharmadispatch.com/news/medical-research-powering-australias-health-and-economic-future 2026-03-31T13:00:01+11:00 https://pharmadispatch.com/news/biosimilar-uptake-remains-low-in-australia-despite-rising-biologic-expenditure 2026-04-07T12:00:01+10:00 https://pharmadispatch.com/news/a-process-getting-underway-must-focus-on-making-the-system-netter-not-just-cheaper 2026-03-31T15:13:01+11:00 https://pharmadispatch.com/news/locally-developed-therapy-reaches-australian-patients-through-pbs-listing 2026-04-01T13:00:01+11:00 https://pharmadispatch.com/news/pbs-expands-treatment-options-for-rare-diseases-with-april-listings 2026-04-01T05:36:01+11:00 https://pharmadispatch.com/news/gbma-appoints-new-ceo-to-lead-next-phase-of-affordable-medicines-in-australia 2026-04-01T05:41:01+11:00 https://pharmadispatch.com/news/patients-australia-survey-reveals-some-targets-to-address-barriers-to-biosimilar-uptake 2026-04-01T05:54:01+11:00 https://pharmadispatch.com/news/biogen-to-acquire-apellis-in-significant-bet-on-rare-disease-growth 2026-04-01T14:56:01+11:00 https://pharmadispatch.com/news/us-confirmed-trade-concerns-with-australia-and-new-zealand-on-pharmaceuticals-and-ip 2026-04-02T13:00:01+11:00 https://pharmadispatch.com/news/i-use-the-monitoring-technology-intermittently-when-i-can-afford-it 2026-04-08T12:00:01+10:00 https://pharmadispatch.com/news/a-call-to-value-life-through-faster-and-fairer-access-to-medicines-in-new-zealand 2026-04-02T13:00:01+11:00 https://pharmadispatch.com/news/law-change-clears-path-for-nationwide-rollout-of-rsv-protection-for-australian-infants 2026-04-02T13:00:01+11:00 https://pharmadispatch.com/news/pets-at-the-heart-of-healing-as-new-campaign-invites-australians-to-share-their-stories 2026-04-02T13:00:01+11:00 https://pharmadispatch.com/news/new-partnership-expands-access-to-menopause-therapy-for-australian-women 2026-04-02T13:00:01+11:00 https://pharmadispatch.com/news/engineered-immune-cells-show-striking-durability-against-hard-to-treat-cancers 2026-04-02T01:30:01+11:00 https://pharmadispatch.com/news/clearing-the-path-for-neurons-as-new-data-strengthens-case-for-nuz-001 2026-04-02T01:36:01+11:00 https://pharmadispatch.com/news/adalta-reports-positive-tumour-responses-in-advanced-mesothelioma-trial 2026-04-02T01:42:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-2-april 2026-04-03T01:09:01+11:00 https://pharmadispatch.com/news/it-was-a-least-a-signal-possibly-a-statement-of-intent-and-even-a-revelation 2026-04-07T12:00:01+10:00 https://pharmadispatch.com/news/families-issue-urgent-call-for-access-to-life-changing-eczema-treatment 2026-04-07T12:00:01+10:00 https://pharmadispatch.com/news/the-rationale-for-a-higher-us-pharmaceutical-tariff-looks-very-familiar-from-here 2026-04-07T12:00:01+10:00 https://pharmadispatch.com/news/algorae-pharmaceuticals-secures-fresh-capital-to-accelerate-ai-driven-drug-strategy 2026-04-06T23:21:01+10:00 https://pharmadispatch.com/news/clinuvel-spotlights-vitiligo-progress-and-long-term-safety-data-at-major-dermatology-gathering 2026-04-06T23:25:01+10:00 https://pharmadispatch.com/news/vitura-health-names-justin-james-as-ceo-to-drive-next-phase-of-growth 2026-04-06T23:43:01+10:00 https://pharmadispatch.com/news/medicines-australia-builds-new-communications-team-with-media-appointment 2026-04-07T02:42:01+10:00 https://pharmadispatch.com/news/sanofis-liz-selby-we-dont-lack-ideas-but-we-do-lack-alignment 2026-04-08T12:00:01+10:00 https://pharmadispatch.com/news/australian-companies-downplay-us-tariff-risk-as-csl-and-mayne-signal-limited-impact 2026-04-08T12:01:01+10:00 https://pharmadispatch.com/news/australian-nuclear-medicine-reports-strong-revenue-growth-and-advances-pipeline 2026-04-08T00:21:01+10:00 https://pharmadispatch.com/news/rewriting-the-rules-of-pbs-negotiations-to-deliver-a-patient-first-reset 2026-04-10T12:00:01+10:00 https://pharmadispatch.com/news/a-flexible-option-for-rett-syndrome-sare-with-broader-access-to-neuren-therapy 2026-04-08T20:26:01+10:00 https://pharmadispatch.com/news/immutep-reassesses-and-resets-lead-cancer-program-following-trial-setback 2026-04-08T20:33:01+10:00 https://pharmadispatch.com/news/orthocell-shrugs-off-us-tariff-threat-as-australian-biotechs-play-down-impact 2026-04-08T20:56:01+10:00 https://pharmadispatch.com/news/it-is-imperative-to-very-carefully-read-what-minister-said-and-then-hear-it 2026-04-09T12:00:01+10:00 https://pharmadispatch.com/news/a-frontline-of-everyday-healthcare-and-its-critical-role-in-addressing-stigma 2026-04-09T00:29:01+10:00 https://pharmadispatch.com/news/stuart-dignam-joins-mtpconnect-board-as-it-embarks-its-second-decade 2026-04-09T00:41:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-announces-a-shift-in-treatment-for-blood-cancer 2026-04-09T20:28:01+10:00 https://pharmadispatch.com/news/moderna-names-carolyn-tucek-szabo-to-lead-australia-and-new-zealand-operations 2026-04-09T20:45:01+10:00 https://pharmadispatch.com/news/a-decade-of-readiness-as-avita-medical-expands-burn-response-capability 2026-04-09T21:15:01+10:00 https://pharmadispatch.com/news/is-there-any-example-of-another-review-or-inquiry-taking-this-long 2026-04-10T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-10-april 2026-04-10T22:01:01+10:00 https://pharmadispatch.com/news/lower-official-co-payment-but-patients-paying-for-more-unsubsidised-medicines 2026-04-10T22:35:01+10:00 https://pharmadispatch.com/news/cartherics-and-catalent-deepen-partnership-to-accelerate-next-generation-cell-therapies 2026-04-10T23:04:01+10:00 https://pharmadispatch.com/news/hta-review-timeline-set-to-extend-well-into-the-second-half-of-2027 2026-04-13T12:00:01+10:00 https://pharmadispatch.com/news/the-endpoint-now-coming-into-view-was-in-truth-always-the-most-likely-one 2026-04-12T20:43:01+10:00 https://pharmadispatch.com/news/australia-risks-falling-further-behind-on-access-to-new-medicines-without-action-industry-warns 2026-04-13T12:00:01+10:00 https://pharmadispatch.com/news/telix-signs-new-cancer-development-deal-with-regeneron 2026-04-13T19:21:01+10:00 https://pharmadispatch.com/news/argent-biopharma-advances-epilepsy-strategy-with-cannpal-acquisition 2026-04-13T19:47:01+10:00 https://pharmadispatch.com/news/what-germany-understands-about-health-technology-assessment-that-australia-does-not-yet 2026-04-14T12:00:01+10:00 https://pharmadispatch.com/news/pbs-listings-reflect-policy-choices-more-than-invented-and-ill-defined-corporate-obligations 2026-04-15T12:00:01+10:00 https://pharmadispatch.com/news/percheron-secures-fresh-funding-to-accelerate-cancer-therapy-ambitions 2026-04-15T00:18:01+10:00 https://pharmadispatch.com/news/bpdinsightsai-is-rethinking-how-we-can-discover-and-understand-information 2026-04-15T12:00:01+10:00 https://pharmadispatch.com/news/pfizer-names-interim-lead-for-australia-and-new-zealand-operations 2026-04-14T12:00:01+10:00 https://pharmadispatch.com/news/orthocell-advances-into-us-military-healthcare-with-nerve-repair-approval 2026-04-15T21:45:01+10:00 https://pharmadispatch.com/news/akesa-enters-japan-with-strategic-leadership-hire-to-navigate-complex-clinical-trial-landscape 2026-04-15T21:49:01+10:00 https://pharmadispatch.com/news/pyc-advances-experimental-therapy-for-inherited-blindness-into-next-phase-of-clinical-testing 2026-04-15T21:55:01+10:00 https://pharmadispatch.com/news/noxopharm-appoints-dr-olivier-laczka-as-ceo-to-lead-next-phase-of-growth 2026-04-15T22:11:01+10:00 https://pharmadispatch.com/news/pharmacy-prescribing-reform-signals-shift-in-nsw-primary-care-with-victoria-to-follow 2026-04-15T23:28:01+10:00 https://pharmadispatch.com/news/fda-moves-to-strengthen-safety-standards-for-genome-editing-therapies 2026-04-15T12:00:01+10:00 https://pharmadispatch.com/news/why-us-health-spending-looks-much-higher-than-it-really-is 2026-04-16T12:00:01+10:00 https://pharmadispatch.com/news/why-hospitals-and-not-medicines-dominate-americas-health-spending-gap 2026-04-17T12:00:01+10:00 https://pharmadispatch.com/news/australia-and-the-us-different-choices-about-health-systems-with-access-and-equity-trade-offs 2026-04-17T12:00:01+10:00 https://pharmadispatch.com/news/new-strategic-alliance-for-biointelect-aims-to-fast-track-life-sciences-innovation 2026-04-17T12:00:01+10:00 https://pharmadispatch.com/news/mark-butler-confirms-new-and-expanded-cancer-medicine-listings 2026-04-17T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-17-april 2026-04-18T00:23:01+10:00 https://pharmadispatch.com/news/free-rsv-vaccines-roll-out-to-protect-senior-australians-ahead-of-winter 2026-04-20T12:00:01+10:00 https://pharmadispatch.com/news/australias-drug-pricing-dogma-risks-failing-patients-in-the-face-of-international-realities 2026-04-20T12:00:01+10:00 https://pharmadispatch.com/news/australian-dementia-experts-push-back-on-cochrane-review-defending-new-treatments 2026-04-20T12:00:01+10:00 https://pharmadispatch.com/news/immuron-posts-steady-global-gains-as-travelan-drives-third-quarter-sales-growth 2026-04-19T22:38:01+10:00 https://pharmadispatch.com/news/alterity-strengthens-board-with-seasoned-biotech-leader-as-it-advances-flagship-therapy 2026-04-19T22:43:01+10:00 https://pharmadispatch.com/news/patrys-secures-fresh-funding-to-push-delirium-therapy-toward-human-trials 2026-04-20T20:10:01+10:00 https://pharmadispatch.com/news/emyria-bets-on-global-demand-for-next-generation-mental-health-treatments 2026-04-20T20:14:01+10:00 https://pharmadispatch.com/news/the-continuing-but-quiet-surge-in-the-use-of-ai-for-health-information 2026-04-21T12:00:01+10:00 https://pharmadispatch.com/news/tga-approves-new-combination-therapy-for-aggressive-lung-cancer 2026-04-21T12:00:01+10:00 https://pharmadispatch.com/news/setting-the-standard-for-pharmacist-prescribing-across-australia 2026-04-21T12:00:01+10:00 https://pharmadispatch.com/news/while-the-government-confronts-ndis-reality-ww-are-still-stuck-with-the-black-knight-on-hta 2026-04-22T12:00:01+10:00 https://pharmadispatch.com/news/trajan-taps-insider-for-finance-leadership-as-it-navigates-transition 2026-04-22T01:59:01+10:00 https://pharmadispatch.com/news/recce-clears-key-regulatory-hurdle-in-indonesia-as-phase-3-trial-advances-toward-approval 2026-04-22T02:03:01+10:00 https://pharmadispatch.com/news/invion-advances-skin-cancer-trial-into-largest-patient-group-after-encouraging-early-results 2026-04-22T02:07:01+10:00 https://pharmadispatch.com/news/starpharma-secures-fda-backing-as-dep-her2-moves-toward-first-human-trial 2026-04-22T02:12:01+10:00 https://pharmadispatch.com/news/medicines-australia-brings-political-and-media-experience-into-senior-advocacy-role 2026-04-22T02:53:01+10:00 https://pharmadispatch.com/news/noxopharm-advances-lupus-therapy-with-data-pointing-to-durable-skin-targeting-and-low-systemic-e 2026-04-22T19:43:01+10:00 https://pharmadispatch.com/news/amplia-positions-narmafotinib-as-a-potential-step-change-in-pancreatic-cancer 2026-04-22T19:48:01+10:00 https://pharmadispatch.com/news/cochlear-navigates-near-term-headwinds-while-doubling-down-on-global-growth-ambitions 2026-04-22T20:43:01+10:00 https://pharmadispatch.com/news/measures-weve-introduced-to-control-spending-are-simply-not-working-as-we-intended 2026-04-22T22:43:01+10:00 https://pharmadispatch.com/news/a-second-mark-butler-speeches-that-offers-an-important-guide-to-the-what-next 2026-04-23T12:00:01+10:00 https://pharmadispatch.com/news/early-signals-strengthen-australian-companys-case-for-next-generation-cancer-immunotherapies 2026-04-23T02:51:01+10:00 https://pharmadispatch.com/news/boehringer-and-heart-of-australia-take-mobile-lung-care-deeper-into-regional-australia 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/a-western-sydney-gp-experiment-is-quietly-helping-to-reshape-the-hospital-equation 2026-04-23T20:32:01+10:00 https://pharmadispatch.com/news/a-decade-to-diagnosis-highlights-hidden-burden-of-immune-disorders 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/ndis-fraud-is-so-extensive-that-prosecuting-their-way-out-of-it-is-now-impractical 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/australia-stakes-its-claim-in-rna-medicines-with-landmark-sydney-facility 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/quiet-diplomacy-as-australia-navigates-global-pricing-pressure-but-can-it-work 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/new-immunotherapy-option-approved-for-australians-with-relapsed-follicular-lymphoma 2026-04-24T12:00:01+10:00 https://pharmadispatch.com/news/prevention-warning-as-pfizer-urges-budget-reset-on-vaccines-and-immunisation 2026-04-24T19:29:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-24-april 2026-04-25T00:11:01+10:00 https://pharmadispatch.com/news/australias-vaccine-research-strength-exposed-by-persistent-translation-gap 2026-04-28T12:00:01+10:00 https://pharmadispatch.com/news/quarter-of-a-century-after-the-case-that-led-to-the-pbacs-unaccountability-loop 2026-04-28T12:00:01+10:00 https://pharmadispatch.com/news/this-makes-it-twice-in-two-weeks-so-at-what-point-do-we-accept-theres-a-problem 2026-04-28T12:00:01+10:00 https://pharmadispatch.com/news/a-renewed-push-to-lift-vaccination-rates-as-risks-rise-for-children-and-older-australians 2026-04-26T20:53:01+10:00 https://pharmadispatch.com/news/outcomes-delivers-disappointment-for-vaccine-advocates-but-progress-on-paediatric-access-to-biol 2026-04-28T12:00:01+10:00 https://pharmadispatch.com/news/lillys-mounjaro-will-not-be-listed-on-pbs-because-of-unrealistic-recommendation 2026-04-28T12:00:01+10:00 https://pharmadispatch.com/news/we-need-to-say-it-again-just-in-case-that-this-advice-is-about-ministerial-choices-and-not-condi 2026-04-29T11:00:01+10:00 https://pharmadispatch.com/news/let-me-once-again-explain-why-we-must-close-the-gap-for-people-with-cystic-fibrosisrelated-diabe 2026-04-29T11:00:01+10:00 https://pharmadispatch.com/news/sun-pharma-to-acquire-organon-in-deal-that-aims-to-build-its-global-footprint 2026-04-29T00:35:01+10:00 https://pharmadispatch.com/news/families-welcome-cancer-drug-progress-but-caution-remains-over-timely-access 2026-04-29T01:58:01+10:00 https://pharmadispatch.com/news/how-do-we-know-the-institution-loves-patients-because-they-use-a-love-heart-emoji 2026-04-30T12:00:01+10:00 https://pharmadispatch.com/news/moderna-taps-salesforce-to-unify-global-commercial-operations 2026-04-30T12:00:01+10:00 https://pharmadispatch.com/news/australia-urged-to-strengthen-sunscreen-literacy-and-label-clarity 2026-04-30T00:55:01+10:00 https://pharmadispatch.com/news/australian-company-secures-capital-raise-to-advance-amsulostat-trials-and-strengthen-pipeline 2026-04-30T01:09:01+10:00 https://pharmadispatch.com/news/ucb-marks-25-years-in-australia-and-advances-national-life-science-strategy 2026-05-01T12:00:01+10:00 https://pharmadispatch.com/news/new-oral-treatment-offers-more-options-for-australians-with-metastatic-colorectal-cancer 2026-05-01T00:38:01+10:00 https://pharmadispatch.com/news/stability-now-change-later-fees-unchanged-while-department-undertakes-charging-model-review 2026-05-01T12:00:01+10:00 https://pharmadispatch.com/news/bridge-program-celebrates-ten-years-of-translating-research-into-patient-outcomes 2026-05-01T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-1-may 2026-05-02T01:34:01+10:00 https://pharmadispatch.com/news/six-years-and-a-secret-select-group-of-stakeholders-get-to-engineer-the-outcome 2026-05-03T12:00:01+10:00 https://pharmadispatch.com/news/health-department-launches-closed-delphi-process-to-force-hta-technical-outcome 2026-05-04T12:00:01+10:00 https://pharmadispatch.com/news/health-department-reveals-proposed-new-wording-but-only-to-some 2026-05-04T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-special-episode 2026-05-04T01:44:01+10:00 https://pharmadispatch.com/news/lilly-therapy-approved-in-australia-as-first-non-covalent-btk-inhibitor-for-blood-cancer 2026-05-05T12:00:01+10:00 https://pharmadispatch.com/news/australia-approves-first-in-class-therapy-for-chronic-graft-versus-host-disease 2026-05-05T12:00:01+10:00 https://pharmadispatch.com/news/adalta-secures-funds-to-advance-car-t-therapy-after-positive-clinical-responses 2026-05-04T23:36:01+10:00 https://pharmadispatch.com/news/arovella-announces-board-overhauled-and-ceo-resignation 2026-05-04T23:43:01+10:00 https://pharmadispatch.com/news/cynata-capital-raise-as-it-prepares-for-pivotal-clinical-trial-readouts 2026-05-05T00:53:01+10:00 https://pharmadispatch.com/news/botanix-elevates-executive-to-chief-operating-officer 2026-05-05T01:06:01+10:00 https://pharmadispatch.com/news/psilocybin-assisted-sherapy-shows-high-response-in-treatment-resistant-irritable-bowel-syndrome 2026-05-05T01:12:01+10:00 https://pharmadispatch.com/news/medicines-australia-calls-for-transparency-and-highlights-the-risk-of-bias 2026-05-05T12:00:01+10:00 https://pharmadispatch.com/news/time-to-make-this-targeted-consultation-a-little-less-targeted 2026-05-05T22:59:01+10:00 https://pharmadispatch.com/news/therapy-funded-three-years-after-the-clunky-and-preventable-death-admission 2026-05-05T23:32:01+10:00 https://pharmadispatch.com/news/if-the-imperative-is-international-comparison-why-limit-it-to-these-definitions 2026-05-06T01:12:01+10:00 https://pharmadispatch.com/news/la-trobe-launches-reach-program-to-fight-antimicrobial-resistance 2026-05-06T12:00:01+10:00 https://pharmadispatch.com/news/the-review-is-formally-over-why-is-it-restarting 2026-05-07T12:00:01+10:00 https://pharmadispatch.com/news/ego-pharmaceuticals-celebrated-in-centenary-project-on-royal-and-parliamentary-leadership 2026-05-07T04:01:01+10:00 https://pharmadispatch.com/news/ai-screening-tool-gives-pathologists-super-vision-to-detect-hidden-cancer 2026-05-07T12:00:01+10:00 https://pharmadispatch.com/news/moderna-expands-support-for-early-career-australian-mrna-researchers 2026-05-07T14:17:01+10:00 https://pharmadispatch.com/news/the-approaching-major-change-in-australias-pbs-wholesaling-arrangements 2026-05-08T12:00:01+10:00 https://pharmadispatch.com/news/stakeholders-must-act-to-protect-their-voice-in-response-to-risk-of-a-manufactured-consensus 2026-05-07T22:34:01+10:00 https://pharmadispatch.com/news/victoria-joins-state-funded-menb-program-as-pbac-rejection-create-another-postcode-lottery 2026-05-08T12:00:01+10:00 https://pharmadispatch.com/news/lilly-marks-150-years-by-lighting-a-new-horizon-for-health-at-vivid-sydney 2026-05-08T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-8-may-2026 2026-05-08T23:17:01+10:00 https://pharmadispatch.com/news/it-is-mostly-a-mistake-to-read-too-much-into-a-budget-forecast-because-of-what-it-doesnt-include 2026-05-11T12:00:01+10:00 https://pharmadispatch.com/news/budget-silence-on-hta-review-would-confirm-what-we-already-know-delayed-rollout 2026-05-09T12:00:01+10:00 https://pharmadispatch.com/news/bpdinsights-one-week-out-wit-patient-voices-leading-the-agenda 2026-05-11T12:00:01+10:00 https://pharmadispatch.com/news/csl-signals-course-correction-as-interim-ceo-outlines-revised-outlook-and-major-impairments 2026-05-11T23:12:01+10:00 https://pharmadispatch.com/news/budget-could-back-hta-groundwork-while-significant-reform-waits 2026-05-12T12:00:01+10:00 https://pharmadispatch.com/news/emerging-australian-company-adds-seasoned-industry-executive-to-its-board 2026-05-12T13:16:01+10:00 https://pharmadispatch.com/news/stop-wasting-time-trying-to-convince-this-institution-to-do-something-it-will-never-do 2026-05-12T19:39:01+10:00 https://pharmadispatch.com/news/budget-confirms-what-we-already-knew-and-what-we-had-guessed 2026-05-13T07:00:01+10:00 https://pharmadispatch.com/news/updated-forecast-highlights-the-real-risk-of-relying-on-these-numbers 2026-05-13T12:00:01+10:00 https://pharmadispatch.com/news/budget-pledges-71-million-to-expand-precision-oncology-for-australians-with-advanced-cancer 2026-05-13T12:00:01+10:00 https://pharmadispatch.com/news/disappointment-for-diabetes-advocates-in-response-to-government-budget-silence 2026-05-13T15:02:01+10:00 https://pharmadispatch.com/news/frustrated-minister-encourages-an-early-negotiation-of-new-agreements 2026-05-14T12:00:01+10:00 https://pharmadispatch.com/news/there-are-any-number-of-reasons-to-criticise-the-minister-on-the-pbs-but-he-right-to-be-annoyed- 2026-05-14T12:00:01+10:00 https://pharmadispatch.com/news/government-sidesteps-committee-call-on-cgms-insulin-pumps-and-glp1-access 2026-05-18T12:00:01+10:00 https://pharmadispatch.com/news/gbma-welcomes-budget-pathway-to-increasing-biosimilar-uptake 2026-05-14T12:00:01+10:00 https://pharmadispatch.com/news/long-term-study-finds-continuing-mounjaro-helps-maintain-weight-loss 2026-05-14T12:00:01+10:00 https://pharmadispatch.com/news/baxter-and-mtaa-launch-australian-healthcare-manufacturing-leaders-network 2026-05-13T12:00:01+10:00 https://pharmadispatch.com/news/minister-fired-the-starting-gun-in-march-he-flung-the-door-in-budget-week 2026-05-15T03:26:01+10:00 https://pharmadispatch.com/news/ausbiotech-welcomes-budget-moves-but-cautions-on-unintended-consequences 2026-05-15T12:00:01+10:00 https://pharmadispatch.com/news/new-zealand-still-falling-behind-on-access-to-modern-medicines 2026-05-15T13:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-15-may 2026-05-16T00:38:01+10:00 https://pharmadispatch.com/news/budget-papers-signal-the-work-that-has-already-been-done-on-reform-proposals 2026-05-18T12:00:01+10:00 https://pharmadispatch.com/news/if-the-demand-is-to-pay-for-reform-are-these-reforms-really-worth-paying-for 2026-05-18T12:00:01+10:00 https://pharmadispatch.com/news/perth-hosts-ausmedtech-conference-as-industry-focuses-on-innovation-and-commercialisation 2026-05-19T12:52:01+10:00 https://pharmadispatch.com/news/sandoz-urges-faster-access-to-medicines-as-government-opens-biosimilar-consultation 2026-05-19T12:55:01+10:00 https://pharmadispatch.com/news/new-partnership-expands-access-to-care-for-australians-with-rare-cancers 2026-05-19T13:03:01+10:00 https://pharmadispatch.com/news/sanofi-therapy-wins-australian-registration-for-non-relapsing-secondary-progressive-ms 2026-05-20T12:00:01+10:00 https://pharmadispatch.com/news/australia-bets-on-translational-science-to-turn-discovery-into-global-impact 2026-05-20T02:22:01+10:00 https://pharmadispatch.com/news/owen-smith-we-are-ready-to-negotiate-we-are-ready-to-be-a-genuine-partner 2026-05-20T02:34:01+10:00 https://pharmadispatch.com/news/they-used-to-forecast-growth-it-was-fake-and-couldnt-be-used-and-it-made-the-program-a-target-fo 2026-05-21T12:00:01+10:00 https://pharmadispatch.com/news/new-reports-reveals-how-ai-is-now-deciding-which-healthcare-brands-australians-see-online 2026-05-21T12:00:01+10:00 https://pharmadispatch.com/news/medicine-shortages-and-workforce-gaps-threaten-the-sustainability-of-australian-care 2026-05-21T12:00:01+10:00 https://pharmadispatch.com/news/australias-life-sciences-sector-emerges-as-fast-growing-globally-connected-powerhouse 2026-05-21T12:00:01+10:00 https://pharmadispatch.com/news/industry-chiefs-want-united-front-as-agreement-negotiations-get-underway 2026-05-22T12:00:01+10:00 https://pharmadispatch.com/news/the-sharper-language-will-need-to-be-accompanied-by-even-sharper-actions 2026-05-22T12:00:01+10:00 https://pharmadispatch.com/news/merck-funds-indigenous-stem-leaders-at-macquarie-university 2026-05-22T12:00:01+10:00 https://pharmadispatch.com/news/lundbeck-australia-earns-ninth-consecutive-great-place-to-work-certification 2026-05-22T12:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-and-tenmile-partner-to-accelerate-australian-life-sciences 2026-05-22T12:00:01+10:00 https://pharmadispatch.com/news/like-rearranging-deck-chairs-on-the-titanic-the-ship-is-still-going-to-sink 2026-05-23T20:40:01+10:00 https://pharmadispatch.com/news/the-risk-to-patients-of-this-institution-getting-too-close-to-the-sun 2026-05-25T12:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-launches-survey-in-response-to-budgets-blind-spot-on-rd-impact 2026-05-24T23:33:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-urges-immediate-funding-for-pharmacy-to-vaccinate-in-response-to-outbreak 2026-05-25T00:51:01+10:00 https://pharmadispatch.com/news/new-national-survey-reveals-muscle-health-screening-gap-in-australian-general-practice 2026-05-26T12:00:01+10:00 https://pharmadispatch.com/news/new-zealands-pharmac-consulting-on-new-vaccine-brands-and-wider-flu-access-for-young-children 2026-05-26T12:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-awarded-legal-costs-as-business-expansion-gains-momentum 2026-05-25T22:00:01+10:00 https://pharmadispatch.com/news/this-unique-historical-oddity-says-all-we-need-to-know-about-the-institution 2026-05-26T12:00:01+10:00 https://pharmadispatch.com/news/australias-access-dilemma-and-how-commercial-leaders-have-adapted-over-time 2026-05-27T12:00:01+10:00 https://pharmadispatch.com/news/tga-approves-sanofi-innovation-that-offers-the-chance-to-delay-onset-of-type-1-diabetes 2026-05-27T12:00:01+10:00 https://pharmadispatch.com/news/arcs-launches-national-partnership-to-boost-public-clinical-research-sites 2026-05-27T15:17:01+10:00 https://pharmadispatch.com/news/research-highlighting-gaps-leaving-some-communities-at-greater-risk-as-flu 2026-05-28T12:04:01+10:00 https://pharmadispatch.com/news/a-fraught-process-but-also-an-opportunity-to-reintroduce-ideas-sidelined-by-the-review 2026-05-28T12:00:01+10:00 https://pharmadispatch.com/news/single-infusion-of-lilly-gene-editing-cuts-cholesterol-with-the-company-planning-long-term-study 2026-05-28T03:39:01+10:00 https://pharmadispatch.com/news/ausbiotech-unites-conferences-under-the-banner-of-the-biggest-week-in-biotech 2026-05-29T05:59:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-29-may 2026-05-29T06:51:01+10:00 https://pharmadispatch.com/news/new-zealands-pre-election-budget-boosts-health-spending-but-pharmac-misses-out 2026-05-29T14:56:01+10:00 https://pharmadispatch.com/news/australias-hta-review-closed-loop-process-continues-with-delphi-stage-two 2026-06-01T12:00:01+10:00 https://pharmadispatch.com/news/helpful-evidence-of-how-the-review-is-landing-on-outcomes-to-benefit-a-few-unicorns 2026-06-01T12:00:01+10:00 https://pharmadispatch.com/news/tga-provisional-approval-brings-first-targeted-treatment-for-sod1-linked-als-to-australia 2026-06-01T12:00:01+10:00 https://pharmadispatch.com/news/australia-risk-losing-more-than-jobs-in-its-biopharmaceutical-sector-it-risks-losing-strategic-c 2026-06-02T04:00:01+10:00 https://pharmadispatch.com/news/now-you-can-see-the-next-step-in-the-process-most-are-officially-excluded-from 2026-06-01T22:34:01+10:00 https://pharmadispatch.com/news/oral-ras-inhibitor-doubles-median-survival-and-cuts-death-risk-in-metastatic-pancreatic-cancer 2026-06-02T04:58:01+10:00 https://pharmadispatch.com/news/new-pbs-listings-expands-access-to-blood-cancer-therapies 2026-06-02T04:00:01+10:00 https://pharmadispatch.com/news/ex-ma-executive-named-the-first-ceo-of-medicinal-cannabis-council-australia 2026-06-02T05:41:01+10:00 https://pharmadispatch.com/news/omico-opens-a-new-chapter-in-precision-oncology-research 2026-06-02T06:39:01+10:00 https://pharmadispatch.com/news/invitation-confusion-clouds-delphi-studies-and-captures-medical-device-sector 2026-06-03T12:00:01+10:00 https://pharmadispatch.com/news/health-department-officials-confirm-shift-in-budget-management-of-underspends 2026-06-03T12:00:01+10:00 https://pharmadispatch.com/news/patient-voices-take-centre-stage-at-the-2026-patients-choice-awards 2026-06-03T12:00:01+10:00 https://pharmadispatch.com/news/novo-nordisks-marie-krogh-prize-returns-and-crosses-the-tasman-to-back-early-career-women-in-sci 2026-06-04T12:00:01+10:00 https://pharmadispatch.com/news/study-confirms-pharmacist-led-care-expands-timely-access-to-urinary-tract-infection-treatment-an 2026-06-04T12:00:01+10:00 https://pharmadispatch.com/news/officials-cite-company-consultation-system-changes-and-spending-approvals-to-justify-delay 2026-06-04T12:00:01+10:00 https://pharmadispatch.com/news/an-exchange-that-shows-the-review-now-looks-like-the-plot-line-of-a-classic-movie 2026-06-04T00:00:01+10:00 https://pharmadispatch.com/news/behind-the-reassurances-officials-talk-down-the-prospect-of-an-mfn-impact-on-the-pbs 2026-06-04T12:00:01+10:00 https://pharmadispatch.com/news/new-blueprint-charts-a-potential-policy-path-forward-on-biosimilars 2026-06-04T20:36:01+10:00 https://pharmadispatch.com/news/a-clear-disconnect-between-the-public-and-private-on-most-favored-nation-pricing 2026-06-05T12:00:01+10:00 https://pharmadispatch.com/news/opthea-returns-to-asx-and-works-to-restart-eye-therapy-candidate 2026-06-05T14:26:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-part-one-of-two-special-episodes 2026-06-06T00:02:01+10:00 https://pharmadispatch.com/news/rd-tax-shake-up-risks-sending-australias-biotech-talent-and-jobs-overseas 2026-06-09T13:00:01+10:00 https://pharmadispatch.com/news/omico-is-evolving-tumour-genomics-into-hard-evidence-for-precision-oncology 2026-06-08T13:00:01+10:00 https://pharmadispatch.com/news/it-was-an-unintentionally-revealing-discussion-about-the-history-and-reality-of-agreements 2026-06-09T13:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-the-potential-health-system-benefits-of-pharmacist-prescribing 2026-06-09T13:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-co-founder-kate-vines-recognised-in-kings-birthday-honours 2026-06-09T02:17:01+10:00 https://pharmadispatch.com/news/industry-campaign-highlights-mfn-risk-to-us-jobs-and-the-broader-economy 2026-06-10T12:00:01+10:00 https://pharmadispatch.com/news/australian-company-secures-us-fast-track-for-car-t-in-blood-cancers 2026-06-10T12:00:01+10:00 https://pharmadispatch.com/news/gsk-to-buy-nuvalent-in-major-move-to-acquire-rights-to-late-stage-lung-cancer-candidates 2026-06-10T15:08:01+10:00 https://pharmadispatch.com/news/cartherics-secures-japanese-patent-to-bolster-cell-therapy-push 2026-06-10T20:02:01+10:00 https://pharmadispatch.com/news/arcs-evolves-into-lifesciences-australia-as-part-of-wider-strategic-change 2026-06-11T12:19:01+10:00 https://pharmadispatch.com/news/island-secures-usamriid-partnership-to-advance-galidesivir-dose-study-for-marburg 2026-06-10T21:21:01+10:00 https://pharmadispatch.com/news/sigma-confirms-interest-in-the-acquisition-of-uk-pharmacy-chain-boots 2026-06-10T21:34:01+10:00 https://pharmadispatch.com/news/the-opportunity-to-shift-the-conversation-the-negotiating-dynamic-and-take-back-some-control 2026-06-12T12:00:01+10:00 https://pharmadispatch.com/news/the-changes-could-cause-irreversible-damage-to-our-vibrant-and-world-leading-biotech-medtech-and 2026-06-12T12:00:01+10:00 https://pharmadispatch.com/news/states-and-territory-ministers-warn-against-centralising-ndis-power 2026-06-12T12:00:01+10:00 https://pharmadispatch.com/news/lifesciences-australia-honours-outstanding-professionals-at-mtp-sector-awards-2026 2026-06-12T12:54:01+10:00 https://pharmadispatch.com/news/treat-policy-and-pricing-negotiation-like-planning-a-product-launch 2026-06-15T12:00:01+10:00 https://pharmadispatch.com/news/high-court-to-decide-on-patentterm-extensions-for-formulations-as-gbma-intervenes 2026-06-15T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-14-june 2026-06-15T12:00:01+10:00 https://pharmadispatch.com/news/aradigm-reaches-global-milestone-as-phase-3-osteoarthritis-trial-completes-enrolment 2026-06-15T21:32:01+10:00 https://pharmadispatch.com/news/entropy-neurodynamics-clears-safety-hurdle-for-iv-psilocin-trial-in-binge-eating-disorder 2026-06-15T21:43:01+10:00 https://pharmadispatch.com/news/when-good-policy-becomes-self-defeating-australia-must-at-least-have-a-discussion-about-the-obvi 2026-06-16T12:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-confirms-pricing-the-issue-but-acts-to-create-a-patient-access-program 2026-06-16T12:00:01+10:00 https://pharmadispatch.com/news/these-outcomes-are-mostly-about-the-choices-australia-is-making 2026-06-17T12:00:01+10:00 https://pharmadispatch.com/news/novartis-names-interim-leader-for-australia-and-nz-after-country-president-departs 2026-06-17T12:00:01+10:00 https://pharmadispatch.com/news/australian-company-partners-to-take-innovative-therapy-to-asia 2026-06-17T12:00:01+10:00 https://pharmadispatch.com/news/racura-completes-significant-fund-raise-to-advance-three-clinical-trials 2026-06-17T20:06:01+10:00 https://pharmadispatch.com/news/percheron-completes-hmbd-002-drug-substance-manufacture 2026-06-17T20:09:01+10:00 https://pharmadispatch.com/news/neurizon-secures-gmp-supply-of-monepantel-to-strengthen-nuz-001-commercial-readiness 2026-06-17T20:44:01+10:00 https://pharmadispatch.com/news/is-chinas-international-benchmarking-a-bigger-short-term-risk-to-medicines-access 2026-06-18T12:00:01+10:00 https://pharmadispatch.com/news/life-sciences-leaders-brace-for-class-action-wave-as-dispute-risks-multiply 2026-06-18T12:00:01+10:00 https://pharmadispatch.com/news/australians-want-more-from-healthcare-as-convenience-prevention-and-fragmentation-reshape-care 2026-06-18T12:00:01+10:00 https://pharmadispatch.com/news/gilead-rushes-remdesivir-to-uganda-to-support-ebola-response 2026-06-19T12:00:01+10:00 https://pharmadispatch.com/news/infectious-diseases-across-the-lifespan-is-a-hidden-burden-beyond-the-acute-episode 2026-06-19T12:00:01+10:00 https://pharmadispatch.com/news/rhapsido-approved-in-australia-as-first-oral-targeted-option-for-chronic-spontaneous-urticaria 2026-06-19T01:51:01+10:00 https://pharmadispatch.com/news/australia-life-sciences-sector-welcomes-new-cgt-concession-and-urges-rdti-fixes 2026-06-18T12:00:01+10:00 https://pharmadispatch.com/news/sanofi-volunteers-confront-homelessness-at-vinnies-ceo-sleepout 2026-06-19T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-19-june 2026-06-19T21:06:01+10:00 https://pharmadispatch.com/news/it-seems-that-one-critical-stakeholder-group-is-missing-in-this-website-design 2026-06-22T12:00:01+10:00 https://pharmadispatch.com/news/may-2026-delivers-paediatric-dosing-flexibility-vaccine-decisions-and-policy-updates 2026-06-22T12:00:01+10:00 https://pharmadispatch.com/news/csl-executive-elizabeth-rex-joins-ausbiotech-board-as-observer 2026-06-22T12:00:01+10:00 https://pharmadispatch.com/news/the-need-to-break-this-paradigm-if-we-are-serious-about-meaningful-reform 2026-06-22T12:00:01+10:00 https://pharmadispatch.com/news/us-launches-investigation-into-pharmaceutical-pricing-with-potential-broad-implications 2026-06-23T12:00:01+10:00 https://pharmadispatch.com/news/if-were-incapable-of-delivering-meaningful-change-we-should-hope-the-us-intervenes 2026-06-23T12:00:01+10:00 https://pharmadispatch.com/news/access-delays-in-cancer-medicines-are-costing-australia-productivity-and-livelihoods-and-lives 2026-06-23T12:00:01+10:00 https://pharmadispatch.com/news/auscelerate-emerges-as-new-name-for-mtpconnect-ahead-of-bio-2026 2026-06-22T23:01:01+10:00 https://pharmadispatch.com/news/tax-deal-delays-ndis-overhaul-and-reopens-scrutiny-with-inquiry-extension 2026-06-24T12:00:01+10:00 https://pharmadispatch.com/news/watching-this-system-has-become-like-watching-an-elephant-on-a-unicycle 2026-06-24T12:00:01+10:00 https://pharmadispatch.com/news/uq-drug-qed-203-moves-toward-first-in-human-trials-with-ellison-medical-institute-backing 2026-06-24T15:09:01+10:00 https://pharmadispatch.com/news/new-report-highlights-the-risk-of-inaction-on-diabetes-technology 2026-06-25T12:00:01+10:00 https://pharmadispatch.com/news/key-report-findings-cost-of-inaction-australian-voices-on-equitable-access-to-diabetes-technolog 2026-06-25T12:00:01+10:00 https://pharmadispatch.com/news/new-zealand-last-among-peers-for-publicly-funded-modern-medicines 2026-06-25T12:00:01+10:00 https://pharmadispatch.com/news/avecho-interim-review-clears-path-to-complete-pivotal-phase-3-insomnia-trial 2026-06-24T22:25:01+10:00 https://pharmadispatch.com/news/neurizon-presents-new-mechanistic-evidence-that-nuz-001-restores-proteostasis-and-supports-als-r 2026-06-24T22:34:01+10:00 https://pharmadispatch.com/news/fda-backs-afts-injectable-iron-into-phase-3-study-as-company-targets-global-scale 2026-06-24T22:42:01+10:00 https://pharmadispatch.com/news/early-real-world-data-shows-improvement-in-treatment-resistant-depression 2026-06-24T23:02:01+10:00 https://pharmadispatch.com/news/a-stronger-pbs-makes-way-for-we-are-now-in-a-fight-to-save-the-pbs 2026-06-25T12:00:01+10:00 https://pharmadispatch.com/news/lenz-and-arrotex-partner-to-bring-once-daily-presbyopia-treatment-to-australia-and-new-zealand 2026-06-25T20:43:01+10:00 https://pharmadispatch.com/news/arrotex-and-cstone-partner-to-bring-new-anti-pd-l1-therapy-to-australia-and-new-zealand 2026-06-26T12:00:01+10:00 https://pharmadispatch.com/news/australias-next-industry-agreements-might-put-cancer-biologics-squarely-in-the-frame 2026-06-26T12:00:01+10:00 https://pharmadispatch.com/news/guild-says-pharmacy-the-solution-as-ama-flags-ambulance-ramping-crisis 2026-06-26T12:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-26-june 2026-06-26T22:48:01+10:00 https://pharmadispatch.com/news/surely-this-therapy-is-an-example-of-our-system-at-its-absolute-worst 2026-06-28T18:10:01+10:00 https://pharmadispatch.com/news/officials-highlight-benefits-but-urge-caution-in-rollout-of-ai-driven-medical-scribes 2026-06-29T12:00:01+10:00 https://pharmadispatch.com/news/a-comment-that-highlights-how-complexity-is-making-the-challenge-more-challenging 2026-06-29T12:00:01+10:00 https://pharmadispatch.com/news/two-new-listings-add-treatment-choices-for-growth-hormone-deficiency-and-people-with-type-1-diab 2026-06-29T12:00:01+10:00 https://pharmadispatch.com/news/when-it-comes-to-negotiating-with-government-trust-actions-and-not-words 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/neuren-partner-secures-european-backing-for-rett-syndrome-therapy 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/disappointment-for-csl-as-europe-recommends-reversing-approval-of-therapy 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/new-msd-vaccine-listed-on-national-program-with-expanded-eligibility 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/ipsen-therapy-approved-in-australia-for-rare-genetic-disorder 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/nasal-adrenaline-to-be-added-to-the-pbs-for-people-at-risk-of-anaphylaxis 2026-06-30T12:00:01+10:00 https://pharmadispatch.com/news/protection-gap-leaves-older-australians-vulnerable-this-winter 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-reject-ama-alarm-over-broader-prescribing-powers 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/significant-day-marked-by-negotiation-trigger-and-wholesaler-remuneration-changes 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/governments-backs-inhaled-rna-therapy-with-the-potential-to-change-the-future-of-chronic-lung-di 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/listing-expands-access-to-targeted-therapy-for-australians-living-with-myasthenia-gravis 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/major-new-survey-shows-patients-paying-more-and-waiting-longer-for-medicines 2026-07-01T10:00:01+10:00 https://pharmadispatch.com/news/patient-alarm-over-the-potential-loss-of-subsidised-access-to-ms-medicines 2026-07-01T16:10:01+10:00 https://pharmadispatch.com/news/the-minister-is-following-a-tried-and-tested-process-but-what-is-the-risk-in-this-new-world 2026-07-01T18:56:01+10:00 https://pharmadispatch.com/news/cartherics-emerges-as-asia-pacific-leader-in-off-the-shelf-immune-cell-therapy 2026-07-02T12:00:01+10:00 https://pharmadispatch.com/news/minister-looks-to-be-sending-a-very-clear-message-about-these-therapies-and-the-pbs 2026-07-02T12:00:01+10:00 https://pharmadispatch.com/news/the-end-game-of-strong-arming-companies-over-prices-at-the-expense-of-patients-and-process 2026-07-02T12:00:01+10:00 https://pharmadispatch.com/news/commercial-outsourcing-emerges-as-a-strategic-route-to-faster-patient-access 2026-07-02T01:12:01+10:00 https://pharmadispatch.com/news/nothing-else-grows-below-this-self-serving-and-broken-institutional-framework 2026-07-03T12:00:01+10:00 https://pharmadispatch.com/news/nurse-prescribing-reform-set-to-expand-access-to-pbs-subsidised-medicines 2026-07-03T12:00:01+10:00 https://pharmadispatch.com/news/new-once-weekly-therapy-offers-extended-protection-for-people-with-haemophilia-a 2026-07-03T12:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-chief-says-next-negotiation-is-about-getting-comfortable-with-being-uncomfor 2026-07-03T12:00:01+10:00 https://pharmadispatch.com/news/is-that-a-subtle-but-meaningful-shift-conceding-the-potential-need-for-a-response-to-mfn 2026-07-03T20:13:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-season-5-episode-22 2026-07-03T23:14:01+10:00 https://pharmadispatch.com/news/a-performative-change-that-still-leaves-the-door-open-for-a-response-to-mfn-risk 2026-07-06T12:00:01+10:00 https://pharmadispatch.com/news/new-law-proposes-limiting-trade-ministers-power-over-pbs-concessions 2026-07-06T12:00:01+10:00 https://pharmadispatch.com/news/widespread-use-of-statins-nnarrows-heart-risk-gap-between-overweight-and-normal-weight-adults 2026-07-06T12:00:01+10:00 https://pharmadispatch.com/news/an-attempt-to-create-yet-another-excuse-to-avoid-a-meaningful-discussion-about-change-2 2026-07-07T12:00:01+10:00 https://pharmadispatch.com/news/australian-healthcare-associates-retains-deal-to-administer-the-cso-funding-pool-through-2029 2026-07-07T12:00:01+10:00 https://pharmadispatch.com/news/early-clinical-imaging-shows-syntara-candidate-reduces-brain-inflammation-in-people-at-high-risk 2026-07-06T23:07:01+10:00 https://pharmadispatch.com/news/australia-must-keep-development-manufacturing-and-jobs-here-to-secure-health-and-economic-benefi 2026-07-07T12:00:01+10:00 https://pharmadispatch.com/news/vitex-opens-250-million-pharmaceutical-manufacturing-facility-in-western-sydney 2026-07-07T01:11:01+10:00 https://pharmadispatch.com/news/brandon-capital-secures-landmark-novartis-acquisition-of-myricx-bio 2026-07-07T01:38:01+10:00 https://pharmadispatch.com/news/just-in-cast-they-didnt-get-the-message-mark-butler-has-reminded-them-of-the-governments-view 2026-07-08T00:03:01+10:00 https://pharmadispatch.com/news/in-a-perfect-world-the-minister-would-not-be-in-this-position-and-he-might-question-the-timeline 2026-07-08T12:00:01+10:00 https://pharmadispatch.com/news/aegros-completes-australias-second-large-scale-plasma-fractionation-plant 2026-07-08T12:00:01+10:00 https://pharmadispatch.com/news/pyc-therapeutics-names-thomas-ulmer-as-new-chief-financial-officer 2026-07-08T20:54:01+10:00 https://pharmadispatch.com/news/illumina-taps-medtech-leader-to-head-australia-and-new-zealand-operations 2026-07-08T21:00:01+10:00 https://pharmadispatch.com/news/it-might-make-sense-to-follow-the-process-mostly-but-no-real-need-to-keep-patients-waiting 2026-07-09T12:00:01+10:00 https://pharmadispatch.com/news/territory-partnership-backs-digital-health-push-for-diabetes-kidney-and-heart-care 2026-07-09T12:29:01+10:00 https://pharmadispatch.com/news/melbourne-study-links-higher-tumour-radiation-dose-to-longer-progression-free-survival 2026-07-10T12:46:01+10:00 https://pharmadispatch.com/news/older-australians-are-underestimating-their-personal-risk-from-rsv 2026-07-10T12:00:01+10:00 https://pharmadispatch.com/news/disruption-is-the-overdue-remedy-how-this-debate-can-revitalise-the-pbs 2026-07-10T14:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep-23 2026-07-11T01:15:01+10:00 https://pharmadispatch.com/news/the-inevitability-of-disappointment-over-a-reform-process-that-has-devolved-into-word-games 2026-07-12T12:00:01+10:00 https://pharmadispatch.com/news/can-glp-1s-be-more-transformative-than-ai-one-person-believe-they-already-are 2026-07-14T12:00:01+10:00 https://pharmadispatch.com/news/mesoblast-reports-strong-revenue-as-first-year-as-uptake-grows 2026-07-13T12:00:01+10:00 https://pharmadispatch.com/news/what-is-it-with-this-organisations-obsession-with-pharmacy-and-scandinavia 2026-07-13T12:00:01+10:00 https://pharmadispatch.com/news/patrys-and-yale-agree-revenue-share-to-advance-deoxymab-platform 2026-07-13T20:58:01+10:00 https://pharmadispatch.com/news/scenesse-gains-canadian-approval-offering-long-term-protection-for-patients-with-rare-disorder 2026-07-13T21:07:01+10:00 https://pharmadispatch.com/news/oncosil-medical-establishes-scalable-australian-production-after-successful-manufacturing-valida 2026-07-13T21:13:01+10:00 https://pharmadispatch.com/news/immutep-cancer-candidate-shows-strong-median-survival-in-lung-cancer-as-company-consider-conflic 2026-07-13T21:52:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-rejects-grattan-institute-report-describing-community-pharmacies-as-essential-hea 2026-07-13T22:50:01+10:00 https://pharmadispatch.com/news/the-age-old-argument-for-supermarket-pharmacies-misses-the-point-and-the-risks 2026-07-14T11:00:01+10:00 https://pharmadispatch.com/news/a-single-payer-system-in-which-the-worst-kind-of-inequity-is-the-only-one-permitted 2026-07-16T12:00:01+10:00 https://pharmadispatch.com/news/an-opportunity-to-become-a-global-destination-for-paediatric-oncology-trials 2026-07-15T11:00:01+10:00 https://pharmadispatch.com/news/widening-inequality-threatens-outcomes-for-australians-with-neuroendocrine-cancer 2026-07-14T23:52:01+10:00 https://pharmadispatch.com/news/butler-recommits-to-keeping-ms-medicines-on-the-pbs-while-awaiting-formal-advice 2026-07-15T12:00:01+10:00 https://pharmadispatch.com/news/budget-outlook-now-hangs-on-disability-savings-but-what-about-pharmaceuticals 2026-07-15T12:00:01+10:00 https://pharmadispatch.com/news/australian-partnership-advances-gene-therapy-for-retinitis-pigmentosa 2026-07-15T12:00:01+10:00 https://pharmadispatch.com/news/patients-move-to-reclaim-access-agenda-ahead-of-sector-negotiations 2026-07-15T12:00:01+10:00 https://pharmadispatch.com/news/starpharma-raises-32-million-to-advance-dendrimer-cancer-programs 2026-07-15T21:47:01+10:00 https://pharmadispatch.com/news/algorae-names-nasdaq-pharmaceutical-chairman-to-strengthen-board 2026-07-15T21:51:01+10:00 https://pharmadispatch.com/news/organon-and-samsung-bioepis-expand-partnership-to-broaden-biosimilar-access-in-australia 2026-07-16T12:00:01+10:00 https://pharmadispatch.com/news/arthritis-australia-unveils-new-grants-and-identity-as-research-breakthroughs-loom 2026-07-16T12:00:01+10:00 https://pharmadispatch.com/news/telix-opens-australias-first-integrated-radiopharmaceutical-facility-in-melbourne 2026-07-17T01:56:01+10:00 https://pharmadispatch.com/news/ex-novartis-leader-joins-the-board-of-emerging-nuclear-medicine-company 2026-07-17T12:00:01+10:00 https://pharmadispatch.com/news/it-doesnt-always-feel-like-it-but-make-no-mistake-this-is-what-winning-looks-like 2026-07-17T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep-24 2026-07-18T00:00:01+10:00 https://pharmadispatch.com/news/why-is-the-system-slower-than-when-there-was-no-patient-involvement-of-input 2026-07-20T12:00:01+10:00 https://pharmadispatch.com/news/no-company-in-its-right-mind-would-risk-a-large-private-market-for-this-outcome 2026-07-20T12:00:01+10:00 https://pharmadispatch.com/news/novartis-names-anne-harris-to-lead-australia-and-new-zealand 2026-07-20T12:00:01+10:00 https://pharmadispatch.com/news/our-access-our-medicines-our-vaccines-our-medical-technology 2026-07-21T12:00:01+10:00 https://pharmadispatch.com/news/candidate-shows-antidepressant-signal-in-difficult-to-treat-depression 2026-07-21T12:00:01+10:00 https://pharmadispatch.com/news/ltr-pharma-secures-national-us-manufacturing-and-fulfilment-partner 2026-07-21T12:00:01+10:00 https://pharmadispatch.com/news/is-this-is-an-example-of-a-bully-playing-hardball-its-not-the-companies 2026-07-21T20:00:01+10:00 https://pharmadispatch.com/news/australian-approval-for-astrazenecas-nearzero-global-warming-propellant-inhaler 2026-07-22T12:00:01+10:00 https://pharmadispatch.com/news/telix-posts-strong-quarter-as-revenue-nears-billion-dollar-annual-run-rate 2026-07-22T01:28:01+10:00 https://pharmadispatch.com/news/faster-processes-could-push-pharmacs-options-for-investment-backlog-to-400-within-two-years 2026-07-23T12:00:01+10:00 https://pharmadispatch.com/news/how-national-hpv-vaccination-programs-are-changing-the-story-of-cervical-cancer 2026-07-23T12:00:01+10:00 https://pharmadispatch.com/news/proteomics-international-and-healius-team-up-to-take-promarker-tests-national 2026-07-22T21:19:01+10:00 https://pharmadispatch.com/news/radiopharm-theranostics-reports-positive-results-in-tumour-trials 2026-07-22T21:30:01+10:00 https://pharmadispatch.com/news/bls-and-trexapharm-move-to-bring-trexavive-to-australian-patients 2026-07-22T21:42:01+10:00 https://pharmadispatch.com/news/bellberry-and-ascept-release-checklist-for-new-approach-methodologies-trials 2026-07-23T12:00:01+10:00 https://pharmadispatch.com/news/major-brands-and-biosimilars-feature-prominently-on-november-pbac-agenda 2026-07-23T12:00:01+10:00 https://pharmadispatch.com/news/the-end-of-days-language-is-just-a-farcical-attempt-to-shut-down-discussion 2026-07-24T11:00:01+10:00 https://pharmadispatch.com/news/australian-company-moving-headquarters-to-us-and-restructure-workforce 2026-07-24T11:00:01+10:00 https://pharmadispatch.com/news/finalists-named-in-2026-patients-australia-awards 2026-07-24T12:08:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep25 2026-07-24T22:25:01+10:00 https://pharmadispatch.com/news/act-unveils-plan-to-repair-new-zealands-medicines-gap-by-2033 2026-07-26T20:30:01+10:00 https://pharmadispatch.com/news/new-ai-platform-aims-to-give-patients-a-stronger-voice-in-medicines-funding 2026-07-27T11:00:01+10:00 https://pharmadispatch.com/news/bellberry-announces-new-appointment-to-board-of-directors 2026-07-27T11:00:01+10:00 https://pharmadispatch.com/news/the-power-of-this-commitment-might-be-as-a-comparison-of-national-intent 2026-07-27T11:00:01+10:00 https://pharmadispatch.com/news/reform-for-patients-the-focus-of-private-cancer-physicians-summit 2026-07-27T11:00:01+10:00 https://pharmadispatch.com/news/long-covid-still-reshaping-life-for-medically-vulnerable-australians 2026-07-28T11:00:01+10:00 https://pharmadispatch.com/news/australians-with-rare-diseases-still-waiting-too-long-for-access-to-treatments 2026-07-28T11:00:01+10:00 https://pharmadispatch.com/news/ew-research-shows-chronic-pain-is-widespread-and-undertreated-in-australia 2026-07-28T11:00:01+10:00 https://pharmadispatch.com/news/tga-approves-gsks-sixmonthly-treatment-for-severe-eosinophilic-asthma-and-nasal-polyps 2026-07-28T11:00:01+10:00 https://pharmadispatch.com/news/aft-pharmaceuticals-sees-significant-opportunity-in-a-diverse-rd-pipeline 2026-07-28T19:49:01+10:00 https://pharmadispatch.com/news/helping-to-build-australias-life-sciences-future-at-brisbanes-innovation-junction 2026-07-29T11:00:01+10:00 https://pharmadispatch.com/news/abbvie-records-a-13-year-streak-as-a-great-place-to-work 2026-07-29T11:00:01+10:00 https://pharmadispatch.com/news/csl-begins-clinical-trials-to-test-higher-yield-plasma-manufacturing 2026-07-30T11:00:01+10:00 https://pharmadispatch.com/news/ai-will-likely-grow-the-hta-industrial-complex-but-it-can-also-democratise-the-institution 2026-07-30T11:00:01+10:00 https://pharmadispatch.com/news/new-ausbiotech-membership-aims-to-help-australias-early-stage-life-sciences-founders-thrive 2026-07-30T11:00:01+10:00 https://pharmadispatch.com/news/auscelerate-program-channels-major-investment-into-heart-and-diabetes-innovations 2026-07-31T03:37:01+10:00 https://pharmadispatch.com/news/industry-associations-still-resisting-non-disclosure-agreements-for-negotiation 2026-07-31T11:00:01+10:00 https://pharmadispatch.com/news/new-partnership-aims-to-create-national-blueprint-for-earlier-alzheimers-diagnosis-and-care 2026-07-31T15:07:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-31-july 2026-07-31T22:16:01+10:00 https://pharmadispatch.com/news/the-hta-review-and-the-abilene-paradox-when-everyone-argues-for-reforms-that-nobody-wants 2026-08-03T11:00:01+10:00 https://pharmadispatch.com/news/first-new-brain-cancer-treatment-listed-on-pbs-after-more-than-20-years 2026-08-03T11:00:01+10:00 https://pharmadispatch.com/news/listing-offers-treatment-option-for-australians-with-tumour-induced-osteomalacia 2026-08-03T11:00:01+10:00 https://pharmadispatch.com/news/funding-for-new-chemotherapy-free-immunotherapy-combination-for-follicular-lymphoma 2026-08-03T11:00:01+10:00 https://pharmadispatch.com/news/the-risk-to-patients-is-that-new-pricing-policies-could-swamp-any-benefit-from-the-hta-review 2026-08-04T11:00:01+10:00 https://pharmadispatch.com/news/potential-merger-could-create-a-new-global-oncology-powerhouse 2026-08-03T21:41:01+10:00 https://pharmadispatch.com/news/arrotex-pharmaceuticals-appoints-experienced-industry-executive-as-cmo 2026-08-04T11:00:01+10:00 https://pharmadispatch.com/news/this-systems-resistance-patient-power-and-agency-makes-it-a-health-system-outlier 2026-08-05T03:00:01+10:00 https://pharmadispatch.com/news/australian-company-announces-agreement-with-lilly-to-trial-lung-cancer-combination 2026-08-05T03:00:01+10:00 https://pharmadispatch.com/news/pharmac-announced-plan-to-revise-it-recently-expanded-patient-advisory-function 2026-08-05T03:00:01+10:00 https://pharmadispatch.com/news/moderna-begins-phase-1-trial-of-vaccine-candidate-against-bundibugyo-ebola-virus 2026-08-06T11:00:01+10:00 https://pharmadispatch.com/news/neuren-reports-record-daybue-sales-as-royalties-rise-and-global-expansion-nears 2026-08-06T11:00:01+10:00 https://pharmadispatch.com/news/if-australian-companies-resist-the-domestic-market-who-can-blame-multinationals 2026-08-06T11:00:01+10:00 https://pharmadispatch.com/news/nsw-urged-to-think-pharmacy-first-as-250-pharmacists-near-completion-of-advanced-training 2026-08-06T11:00:01+10:00 https://pharmadispatch.com/news/injunction-blocks-generics-launch-of-key-hiv-combination-medicine 2026-08-06T11:00:01+10:00 https://pharmadispatch.com/news/a-new-generation-are-rewriting-their-lives-with-cystic-fibrosis 2026-08-07T11:00:01+10:00 https://pharmadispatch.com/news/argenx-partners-with-monash-university-and-myostellar-to-develop-muscular-therapies 2026-08-07T11:00:01+10:00 https://pharmadispatch.com/news/us-approves-modernas-mrna-flu-vaccine-in-major-technology-milestone 2026-08-07T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-1 2026-08-07T23:45:01+10:00 https://pharmadispatch.com/news/gbma-white-paper-calls-for-reforms-to-strengthen-supply-chain-resilience 2026-08-10T11:00:01+10:00 https://pharmadispatch.com/news/achieving-value-is-meaningless-if-it-undermines-access-to-medicines 2026-08-10T11:00:01+10:00 https://pharmadispatch.com/news/new-zealands-act-announces-plan-for-pharmacies-to-do-a-lot-more-but-also-ownership-and-location- 2026-08-10T11:00:01+10:00 https://pharmadispatch.com/news/france-the-first-to-provide-comprehensive-reimbursement-glp-1s-for-weight-loss-while-australia-l 2026-08-10T11:00:01+10:00 https://pharmadispatch.com/news/australias-biggest-week-in-biotech-brings-global-life-sciences-leaders-to-the-gold-coast 2026-08-09T23:55:01+10:00 https://pharmadispatch.com/news/how-education-reveals-the-terrible-moral-and-ethical-limits-of-our-health-decision-making 2026-08-11T11:00:01+10:00 https://pharmadispatch.com/news/adalta-points-to-encouraging-survival-signal-in-mesothelioma-car-t-study 2026-08-10T22:04:01+10:00 https://pharmadispatch.com/news/percheron-turns-to-former-arovella-chief-michael-baker-for-next-phase-of-hmbd-002-development 2026-08-10T22:12:01+10:00 https://pharmadispatch.com/news/former-minister-joins-dbg-health-board-as-company-broadens-healthcare-ambition 2026-08-12T11:00:01+10:00 https://pharmadispatch.com/news/a-sage-appointment-that-puts-dbg-health-another-step-closer-to-a-serious-understanding-of-decisi 2026-08-12T11:00:01+10:00 https://pharmadispatch.com/news/survey-exposes-deep-gaps-in-neurological-care-across-australia 2026-08-13T11:00:01+10:00 https://pharmadispatch.com/news/us-childhood-vaccine-move-away-from-combinations-contrasts-with-australias-national-schedule 2026-08-12T11:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-the-timely-pbs-listing-of-rare-cancer-therapy 2026-08-12T11:00:01+10:00 https://pharmadispatch.com/news/australia-is-not-an-island-and-we-cannot-be-so-arrogant-to-expect-free-product 2026-08-13T11:00:01+10:00 https://pharmadispatch.com/news/an-institution-dominated-by-very-clever-people-but-where-is-the-wisdom 2026-08-14T11:00:01+10:00 https://pharmadispatch.com/news/a-plain-language-version-of-the-dreadful-and-useless-documents 2026-08-14T11:00:01+10:00 https://pharmadispatch.com/news/vvmf-and-optosleep-partner-to-advance-australian-gene-therapy-for-sleep-apnoea 2026-08-14T02:09:01+10:00 https://pharmadispatch.com/news/medicines-australia-appoints-former-abbvie-executive-jodie-wilson-to-key-leadership-role 2026-08-14T02:14:01+10:00 https://pharmadispatch.com/news/cureator-backs-six-australian-startups-with-135-million-to-advance-new-health-technologies 2026-08-14T04:44:01+10:00 https://pharmadispatch.com/news/melbourne-biotech-pursues-an-oral-path-to-changing-type-1-diabetes 2026-08-15T01:03:01+10:00 https://pharmadispatch.com/news/has-any-patient-ever-said-they-accept-a-rejection-because-of-the-kaplan-meier-curve 2026-08-17T11:00:01+10:00 https://pharmadispatch.com/news/pharmac-aims-to-pivot-toward-faster-processes-and-a-broader-value-framework 2026-08-17T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep28 2026-08-17T03:57:01+10:00 https://pharmadispatch.com/news/oncosil-secures-fda-approval-for-targeted-bile-duct-cancer-device 2026-08-17T20:12:01+10:00 https://pharmadispatch.com/news/dimerix-takes-control-of-us-development-pathway-for-new-kidney-injury-treatment 2026-08-17T20:16:01+10:00 https://pharmadispatch.com/news/mesoblast-completes-treatment-in-pivotal-low-back-pain-trial-as-phase-3-readout-approaches 2026-08-17T20:23:01+10:00 https://pharmadispatch.com/news/australias-biosimilar-policy-failure-has-become-impossible-to-ignore 2026-08-18T11:00:01+10:00 https://pharmadispatch.com/news/opportunity-2-ai-can-democratise-hta-and-the-negotiatios-must-not-squander-it 2026-08-18T11:00:01+10:00 https://pharmadispatch.com/news/vinnies-named-inaugural-partner-of-pharmacy-guild-foundation 2026-08-18T11:00:01+10:00 https://pharmadispatch.com/news/opportunity-3-finally-deliver-on-the-repeated-claims-of-patient-centricity 2026-08-19T11:00:01+10:00 https://pharmadispatch.com/news/csl-absorbs-loss-in-reset-year-as-investors-back-its-plasma-led-recovery 2026-08-18T20:52:01+10:00 https://pharmadispatch.com/news/departmental-restructure-separates-pbs-financing-from-pharmacy-services 2026-08-19T11:00:01+10:00 https://pharmadispatch.com/news/wesfarmers-health-evolves-its-loyalty-program-with-new-pulse-rewards 2026-08-19T11:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-backs-confidential-care-for-rural-health-professionals-in-southern-nsw 2026-08-19T11:00:01+10:00 https://pharmadispatch.com/news/opportunity-4-scope-creep-demands-stronger-checks-and-balances 2026-08-19T11:00:01+10:00 https://pharmadispatch.com/news/new-zealand-researchers-honoured-for-work-tackling-superbugs-and-blood-cancer 2026-08-20T11:00:01+10:00 https://pharmadispatch.com/news/recce-advances-pivotal-diabetic-foot-infection-trial-with-active-antibiotic-comparator-arm 2026-08-20T11:00:01+10:00 https://pharmadispatch.com/news/rare-autoimmune-diseases-impose-a-12-billion-annual-burden-on-australians 2026-08-20T11:00:01+10:00 https://pharmadispatch.com/news/opportunity-5-from-the-hardest-thing-to-secure-to-the-easiest-thing-to-get-right 2026-08-21T11:00:01+10:00 https://pharmadispatch.com/news/biogen-bolsters-leadership-ranks-as-it-sharpens-focus-on-patient-access-and-innovation 2026-08-21T11:00:01+10:00 https://pharmadispatch.com/news/personalised-mrna-cancer-therapy-clears-phase-3-milestone-in-resected-melanoma 2026-08-21T11:00:01+10:00 https://pharmadispatch.com/news/advent-moves-to-acquire-majority-stake-in-nzcr-group 2026-08-21T11:00:01+10:00 https://pharmadispatch.com/news/idt-australia-targets-profitability-after-reporting-sharply-narrowing-loss 2026-08-21T11:14:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep29 2026-08-21T21:14:01+10:00 https://pharmadispatch.com/news/july-2026-pbac-outcomes-recommendations-across-oncology-rare-disease-and-chronic-care 2026-08-24T11:00:01+10:00 https://pharmadispatch.com/news/these-rarely-stated-realities-need-to-be-discussed-in-the-open-more-often 2026-08-24T11:00:01+10:00 https://pharmadispatch.com/news/the-claim-australia-cannot-invest-more-in-new-medicines-fails-very-quickly 2026-08-24T11:00:01+10:00 https://pharmadispatch.com/news/avecho-moves-to-deepen-global-partnering-push-as-cbd-insomnia-program-advances 2026-08-24T20:25:01+10:00 https://pharmadispatch.com/news/acrux-brings-experienced-clinical-leader-aboard-to-advance-testosterone-program 2026-08-24T20:33:01+10:00 https://pharmadispatch.com/news/australian-study-finds-maternal-rsv-vaccination-offers-strong-protection-for-young-infants 2026-08-25T11:00:01+10:00 https://pharmadispatch.com/news/insurers-warn-cut-could-hit-australians-most-likely-to-need-cancer-care 2026-08-25T11:00:01+10:00 https://pharmadispatch.com/news/australia-cannot-deliver-meaningful-change-until-the-levers-of-power-are-rebalanced 2026-08-26T11:00:01+10:00 https://pharmadispatch.com/news/australian-company-secures-european-approval-for-rare-disease-treatment 2026-08-26T11:00:01+10:00 https://pharmadispatch.com/news/professor-brandon-wainwright-appointed-to-lead-qimr-berghofer 2026-08-26T03:55:01+10:00 https://pharmadispatch.com/news/genetic-signatures-and-microba-explore-merger-to-build-infectious-disease-diagnostics-group 2026-08-26T20:02:01+10:00 https://pharmadispatch.com/news/starpharma-narrows-loss-as-genentech-deal-lifts-revenue-and-new-funding-extends-runway 2026-08-26T20:09:01+10:00 https://pharmadispatch.com/news/neurens-first-dividend-signals-a-new-phase-built-on-daybue-royalties 2026-08-26T20:13:01+10:00 https://pharmadispatch.com/news/entropy-takes-trp-8803-to-the-us-in-head-to-head-depression-trial 2026-08-26T20:20:01+10:00 https://pharmadispatch.com/news/argent-biopharma-takes-cannepil-into-us-veterinary-regulatory-process 2026-08-26T20:26:01+10:00 https://pharmadispatch.com/news/noxopharm-pushes-sofra-platform-towards-cancer-proof-of-concept 2026-08-26T20:43:01+10:00 https://pharmadispatch.com/news/australian-company-secures-mitsubishi-partnership-to-bring-biopqq-to-market 2026-08-26T23:52:01+10:00 https://pharmadispatch.com/news/cathy-freeman-to-headline-2026-patients-choice-awards 2026-08-27T11:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-bets-on-womens-health-and-direct-distribution-after-a-difficult-year 2026-08-28T11:00:01+10:00 https://pharmadispatch.com/news/cheaper-medicines-save-australians-14-billion-as-pharmacists-urge-freeze-for-all-patients 2026-08-28T11:00:01+10:00 https://pharmadispatch.com/news/patients-australia-put-healthcares-quiet-achievers-in-the-spotlight 2026-08-28T11:00:01+10:00 https://pharmadispatch.com/news/a-decade-is-more-than-enough-the-case-for-term-limits-on-advisory-committees 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/weight-loss-medicines-drive-revenue-sales-growth-for-sigma-and-wesfarmers-health 2026-08-28T11:00:01+10:00 https://pharmadispatch.com/news/sandoz-earns-top-workplace-recognition-amid-push-for-medicine-access 2026-08-28T14:57:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-series-5-ep30 2026-08-29T00:00:01+10:00 https://pharmadispatch.com/news/september-agenda-puts-cancer-drugs-rsv-prevention-and-adhd-access-in-focus 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/expansion-opens-pbs-access-for-more-with-advanced-cancer-but-it-too-a-long-time 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/funding-brings-a-new-targeted-treatment-for-australians-with-lupus-kidney-disease 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/sanofi-urges-australia-to-look-beyond-the-laboratory-in-building-vaccine-capability 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/astellas-australia-turns-to-rare-disease-leader-guillaume-pfeiffer-for-next-chapter 2026-08-31T11:00:01+10:00 https://pharmadispatch.com/news/tetratherix-sends-first-commercial-polymer-shipment-to-united-states 2026-08-31T19:43:01+10:00 https://pharmadispatch.com/news/avecho-resumes-pivotal-insomnia-trial-recruitment-after-positive-interim-review 2026-08-31T19:50:01+10:00 https://pharmadispatch.com/news/people-who-ask-questions-and-critique-the-process-are-treated-as-people-who-question-and-critiqu 2026-09-01T11:00:01+10:00 https://pharmadispatch.com/news/alterity-secures-option-underwriting-as-it-prepares-for-pivotal-msa-trial 2026-08-31T20:30:01+10:00 https://pharmadispatch.com/news/new-zealand-to-fund-flu-vaccines-for-all-children-under-five-from-2027 2026-09-01T11:00:01+10:00 https://pharmadispatch.com/news/private-hospitals-sustain-230000-jobs-despite-756-million-loss 2026-08-31T23:26:01+10:00 https://pharmadispatch.com/news/nucala-therapy-becomes-first-biologic-subsidised-for-australians-with-uncontrolled-copd 2026-09-01T11:00:01+10:00 https://pharmadispatch.com/news/bls-posts-record-earnings-as-overseas-expansion-accelerates 2026-08-31T23:50:01+10:00 https://pharmadispatch.com/news/six-australian-infectious-disease-ventures-share-1048-million-in-biointelect-funding-round 2026-09-01T00:55:01+10:00 https://pharmadispatch.com/news/trust-and-collaboration-take-centre-stage-as-australia-confronts-widening-vaccine-gaps 2026-09-01T11:00:01+10:00 https://pharmadispatch.com/news/the-non-disclosure-agreements-is-just-about-creating-a-zone-of-controlled-silence 2026-09-02T11:00:01+10:00 https://pharmadispatch.com/news/roche-maps-a-new-chapter-with-move-to-new-sydney-cbd-location 2026-09-02T11:00:01+10:00 https://pharmadispatch.com/news/csl-agrees-to-price-certainty-for-a-bigger-us-manufacturing-footprint 2026-09-02T11:00:01+10:00 https://pharmadispatch.com/news/priceline-pharmacy-broadens-womens-health-support-with-new-parenting-program 2026-09-02T11:00:01+10:00 https://pharmadispatch.com/news/telix-completes-bipass-enrolment-as-it-pursues-a-broader-role-for-psma-pet 2026-09-02T21:25:01+10:00 https://pharmadispatch.com/news/vitrafy-takes-its-cryopreservation-technology-into-the-us-cell-therapy-market 2026-09-02T21:30:01+10:00 https://pharmadispatch.com/news/oncosil-pursues-a-reimbursement-pathway-as-it-prepares-for-us-rollout 2026-09-02T22:02:01+10:00 https://pharmadispatch.com/news/ena-respiratory-secures-funding-to-test-antiviral-nasal-spray-in-people-with-asthma 2026-09-02T22:11:01+10:00 https://pharmadispatch.com/news/the-live-lesson-from-the-uk-on-who-holds-the-levers-and-how-they-use-them 2026-09-03T11:00:01+10:00 https://pharmadispatch.com/news/gilead-returns-to-medicines-australia-as-industry-prepares-to-make-the-case-for-innovation 2026-09-03T11:00:01+10:00 https://pharmadispatch.com/news/combined-monitoring-of-key-indicators-as-the-future-of-diabetes-care 2026-09-03T11:00:01+10:00 https://pharmadispatch.com/news/bms-therapy-secures-australian-approval-for-psoriatic-arthritis 2026-09-03T11:00:01+10:00 https://pharmadispatch.com/news/a-three-ponged-expansion-of-commonwealth-reach-in-therapeutic-goods-regulation 2026-09-04T11:00:01+10:00 https://pharmadispatch.com/news/if-the-government-gives-itself-more-power-dont-be-surprised-when-they-use-it 2026-09-04T11:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-calls-for-doubling-of-pbs-medicines-investment 2026-09-04T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-4-september 2026-09-04T21:33:01+10:00 https://pharmadispatch.com/news/australia-can-set-a-medicines-investment-target-but-how-does-it-deliver 2026-09-07T11:00:01+10:00 https://pharmadispatch.com/news/five-years-1826-days-and-we-are-still-going-on-the-hta-review 2026-09-07T11:00:01+10:00 https://pharmadispatch.com/news/americans-assessing-glp-1s-for-weight-via-government-programs-while-australia-dithers 2026-09-06T11:00:01+10:00 https://pharmadispatch.com/news/one-of-the-review-recommendations-that-should-be-reconsidered-because-of-time 2026-09-08T11:00:01+10:00 https://pharmadispatch.com/news/the-forgotten-patients-living-in-the-long-shadow-of-rare-cancer 2026-09-08T11:00:01+10:00 https://pharmadispatch.com/news/australian-biotech-immuron-takes-gut-health-treatment-to-the-us-market 2026-09-07T04:18:01+10:00 https://pharmadispatch.com/news/pharmacists-could-save-women-millions-and-cut-gp-queues-new-analysis-shows 2026-09-08T11:00:01+10:00 https://pharmadispatch.com/news/neurizon-therapeutics-appoints-chris-bremer-as-chief-executive-to-steer-als-drug-through-final-t 2026-09-07T19:40:01+10:00 https://pharmadispatch.com/news/melbourne-biotech-moves-cell-therapy-from-lab-to-patients 2026-09-07T19:43:01+10:00 https://pharmadispatch.com/news/australia-risks-a-two-tier-health-system-as-patients-take-their-fight-to-canberra 2026-09-08T11:00:01+10:00 https://pharmadispatch.com/news/bupa-to-discontinue-international-referrals-for-doctors-on-demand-telehealth 2026-09-08T02:22:01+10:00 https://pharmadispatch.com/news/what-will-ai-be-capable-of-in-two-months-we-dont-know-and-thats-the-point 2026-09-09T11:00:01+10:00 https://pharmadispatch.com/news/poweroos-chase-world-title-in-argentina-with-new-backing-from-biogen 2026-09-09T11:25:01+10:00 https://pharmadispatch.com/news/you-cant-fix-a-broken-system-by-tinkering-with-parts-of-it 2026-09-09T11:00:01+10:00 https://pharmadispatch.com/news/artificial-intelligence-in-hta-is-arriving-with-or-without-an-agreement-to-govern-it 2026-09-10T11:00:01+10:00 https://pharmadispatch.com/news/guilt-over-this-enduring-failure-is-the-correct-response 2026-09-09T21:08:01+10:00 https://pharmadispatch.com/news/melbourne-oncologist-takes-the-reins-at-australias-private-cancer-physicians-body 2026-09-10T11:00:01+10:00 https://pharmadispatch.com/news/which-is-it-the-two-perspectives-on-patient-input-compounded-by-the-lack-of-transparency 2026-09-10T11:00:01+10:00 https://pharmadispatch.com/news/australia-secures-sovereign-viral-vector-manufacturing-as-vvmf-wins-tga-licence 2026-09-10T11:00:01+10:00 https://pharmadispatch.com/news/taking-a-stake-is-not-the-same-as-spectating-investor-risk-and-expecting-a-benefit 2026-09-11T02:42:01+10:00 https://pharmadispatch.com/news/summit 2026-09-11T03:20:01+10:00 https://pharmadispatch.com/news/rare-genetic-motor-neurone-disease-treatment-finally-reaches-australian-patients 2026-09-11T11:00:01+10:00 https://pharmadispatch.com/news/nsw-pharmacists-to-deliver-all-childhood-vaccines-and-treat-more-conditions-under-reforms 2026-09-11T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-11-september 2026-09-11T23:58:01+10:00 https://pharmadispatch.com/news/canberra-details-tax-changes-with-limited-concessions-for-some-innovators 2026-09-14T11:00:01+10:00 https://pharmadispatch.com/news/scandal-hit-kpmg-still-holds-37-million-in-health-department-work 2026-09-14T11:00:01+10:00 https://pharmadispatch.com/news/todd-stephenson-confirmed-on-act-list-for-new-zealand-election 2026-09-14T11:00:01+10:00 https://pharmadispatch.com/news/fda-clears-telixs-pixclara-as-the-worlds-first-approved-brain-cancer-imaging-drug 2026-09-14T20:40:01+10:00 https://pharmadispatch.com/news/diabetes-and-cancer-blood-tests-reach-wa-and-nt-patients-under-new-healius-deal 2026-09-14T22:07:01+10:00 https://pharmadispatch.com/news/melbourne-biotechs-psychedelic-infusion-keeps-binge-eating-disorder-at-bay-three-months-after-tr 2026-09-14T22:24:01+10:00 https://pharmadispatch.com/news/noxopharm-moves-lupus-skin-therapy-toward-next-human-trial 2026-09-14T22:41:01+10:00 https://pharmadispatch.com/news/persistent-fatigue-could-be-an-overlooked-sign-of-liver-disease 2026-09-15T11:00:01+10:00 https://pharmadispatch.com/news/australias-2026-flu-vaccination-season-barely-moves-the-needle-on-uptake 2026-09-15T11:00:01+10:00 https://pharmadispatch.com/news/a-shorter-name-and-a-bolder-blue-for-novo-nordisk 2026-09-15T13:36:01+10:00 https://pharmadispatch.com/news/young-australians-badly-misjudge-when-fertility-starts-to-decline-new-survey-finds 2026-09-16T11:00:01+10:00 https://pharmadispatch.com/news/new-research-points-to-a-doctor-gap-holding-back-clinical-trial-participation-in-australia 2026-09-16T11:00:01+10:00 https://pharmadispatch.com/news/from-constitutional-promise-to-creaking-system-the-pbs-at-80 2026-09-16T11:00:01+10:00 https://pharmadispatch.com/news/eight-women-named-finalists-for-2026-marie-krogh-young-women-in-science-prize 2026-09-17T11:00:01+10:00 https://pharmadispatch.com/news/new-zealand-ranks-last-among-wealthy-nations-on-modern-medicines-access-new-report-finds 2026-09-16T11:00:01+10:00 https://pharmadispatch.com/news/your-success-makes-you-a-target-and-take-it-as-a-compliment 2026-09-17T02:38:01+10:00 https://pharmadispatch.com/news/genomic-testing-to-reach-more-patients-with-hard-to-treat-cancers 2026-09-17T14:21:01+10:00 https://pharmadispatch.com/news/we-have-one-of-australias-answers-to-mfn-and-people-will-die-as-a-result 2026-09-18T11:00:01+10:00 https://pharmadispatch.com/news/is-the-fairest-part-of-our-medicines-access-system-is-delivered-overseas 2026-09-18T11:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-bets-on-an-untapped-corner-of-the-menopause-market 2026-09-17T22:01:01+10:00 https://pharmadispatch.com/news/queensland-cardiac-experts-back-a-new-plan-to-stop-the-second-heart-attack 2026-09-18T11:00:01+10:00 https://pharmadispatch.com/news/new-ai-contribution-tool-delivers-150-patient-voices-to-the-pbac 2026-09-21T11:00:01+10:00 https://pharmadispatch.com/news/if-ai-is-enhancing-input-then-surely-is-it-doing-the-same-for-output 2026-09-21T11:00:01+10:00 https://pharmadispatch.com/news/officials-are-using-ai-to-create-efficiencies-in-the-hta-evaluation-process 2026-09-21T11:00:01+10:00 https://pharmadispatch.com/news/if-there-is-a-productivity-gain-in-the-process-then-it-should-be-passed-on 2026-09-22T11:00:01+10:00 https://pharmadispatch.com/news/only-2-per-cent-of-australians-can-name-the-signs-of-a-heart-condition-behind-one-in-four-stroke 2026-09-21T20:27:01+10:00 https://pharmadispatch.com/news/telix-announces-takeover-of-itm-to-create-a-global-radiopharmaceutical-powerhouse 2026-09-21T20:32:01+10:00 https://pharmadispatch.com/news/nyrada-banks-12-million-as-directors-tip-in-nearly-half 2026-09-21T21:50:01+10:00 https://pharmadispatch.com/news/treasury-has-moved-on-from-the-pbs-but-the-policies-built-on-its-error-have-not 2026-09-21T22:44:01+10:00 https://pharmadispatch.com/news/given-the-official-use-of-ai-a-cease-and-desist-would-not-be-unreasonable 2026-09-22T11:00:01+10:00 https://pharmadispatch.com/news/who-remembers-the-vancouver-poster-we-have-a-rerun 2026-09-22T11:00:01+10:00 https://pharmadispatch.com/news/the-prevention-gap-and-inside-sally-pantons-bet-on-cellular-health 2026-09-23T11:00:01+10:00 https://pharmadispatch.com/news/pfizer-deeply-disappointed-in-response-to-pbac-refusing-to-move-on-price 2026-09-23T11:00:01+10:00 https://pharmadispatch.com/news/a-multistakeholder-reference-group-to-shadow-agreement-negotiations 2026-09-23T11:00:01+10:00 https://pharmadispatch.com/news/lilly-goes-direct-with-a-patient-platform-for-its-non-pbs-medicines 2026-09-23T11:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-seeks-answers-on-ai-in-hta-process 2026-09-23T11:00:01+10:00 https://pharmadispatch.com/news/patrys-doses-first-volunteers-in-trial-of-intravenous-quetiapine-for-delirium 2026-09-23T20:05:01+10:00 https://pharmadispatch.com/news/actinogens-alzheimers-pill-nears-its-moment-of-truth-as-final-trial-patient-is-seen 2026-09-23T20:12:01+10:00 https://pharmadispatch.com/news/dimerix-draws-17-million-from-loan-facility-to-fund-kidney-drug-trials-to-completion 2026-09-23T20:18:01+10:00 https://pharmadispatch.com/news/seven-australian-startups-share-156-million-to-take-on-dementia 2026-09-23T20:22:01+10:00 https://pharmadispatch.com/news/prescient-raises-6-million-to-carry-cancer-drug-ptx-100-past-a-key-dosing-decision 2026-09-23T20:36:01+10:00 https://pharmadispatch.com/news/ai-is-already-in-the-decision-making-process-but-where-is-conversation-about-its-use 2026-09-24T11:00:01+10:00 https://pharmadispatch.com/news/blood-test-for-eight-cancers-arrives-in-australia-but-misses-almost-half-of-them 2026-09-23T21:20:01+10:00 https://pharmadispatch.com/news/abbvies-top-lawyer-publicly-makes-the-case-against-german-pricing 2026-09-24T11:00:01+10:00 https://pharmadispatch.com/news/englands-genomics-chief-to-share-nhs-lessons-during-australia-visit 2026-09-24T11:00:01+10:00 https://pharmadispatch.com/news/az-to-maintain-breast-cancer-therapy-on-the-pbs-for-six-months-despite-price-rise-knocked-back 2026-09-24T11:00:01+10:00 https://pharmadispatch.com/news/canberra-is-outraged-that-ai-accessed-data-without-asking-others-know-the-feeling 2026-09-24T19:34:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-stays-in-macquarie-park-with-new-anz-headquarters 2026-09-25T11:00:01+10:00 https://pharmadispatch.com/news/pharmac-opens-patient-recruitment-to-new-advisory-committee 2026-09-25T11:00:01+10:00 https://pharmadispatch.com/news/if-ai-causes-a-breach-of-confidentiality-protections-who-is-to-blame 2026-09-25T11:00:01+10:00 https://pharmadispatch.com/news/ai-and-the-fine-print-of-the-governments-health-products-portal 2026-09-25T11:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-1 2026-09-26T01:33:01+10:00 https://pharmadispatch.com/news/dengue-vaccine-arrives-as-australians-carry-the-virus-home-from-holiday-hotspots 2026-09-28T11:00:01+10:00 https://pharmadispatch.com/news/first-new-quit-smoking-drug-in-almost-20-years-arrives-in-australian-pharmacies 2026-09-28T11:00:01+10:00 https://pharmadispatch.com/news/a-gene-therapy-breakthrough-exposes-another-gap-in-newborn-screening 2026-09-28T11:00:01+10:00 https://pharmadispatch.com/news/mayne-pharma-announces-settlement-to-end-us-antitrust-case 2026-09-28T21:06:01+10:00 https://pharmadispatch.com/news/the-design-of-these-programs-including-the-pbs-reflects-constitutional-design 2026-09-29T11:00:01+10:00 https://pharmadispatch.com/news/a-final-budget-outcome-that-only-tells-part-of-the-story 2026-09-29T11:00:01+10:00 https://pharmadispatch.com/news/rd-tax-shake-up-could-push-clinical-trial-jobs-offshore-life-sciences-body-warns 2026-09-29T11:00:01+10:00 https://pharmadispatch.com/news/five-australian-heart-devices-share-42-million-on-world-heart-day 2026-09-29T11:00:01+10:00 https://pharmadispatch.com/news/memphasys-finds-a-faster-route-to-the-us-fertility-market-for-its-felix-separation-system 2026-09-29T04:22:01+10:00 https://pharmadispatch.com/news/nexsen-turns-to-shenzhen-partner-to-speed-up-its-bid-for-the-group-b-strep-market 2026-09-29T04:26:01+10:00 https://pharmadispatch.com/news/biogen-staff-pack-1020-christmas-hampers-for-families-facing-food-insecurity 2026-09-30T11:00:01+10:00 https://pharmadispatch.com/news/australian-broadcast-personality-reveals-the-scars-shingles-left-behind 2026-09-30T11:00:01+10:00 https://pharmadispatch.com/news/research-trials-screen-babies-for-hundreds-of-conditions-while-the-national-program-cant-add-one 2026-09-30T11:00:01+10:00 https://pharmadispatch.com/news/this-represents-a-shuddering-assault-on-free-speech-and-patients 2026-09-30T06:00:01+10:00 https://pharmadispatch.com/news/the-regulator-that-deleted-the-truth-from-its-answers-now-wants-to-police-the-press 2026-10-01T11:00:01+10:00 https://pharmadispatch.com/news/by-the-tgas-own-test-the-health-ministers-press-releases-are-advertising 2026-10-01T11:00:01+10:00 https://pharmadispatch.com/news/eczema-patients-who-dont-respond-to-steroids-get-subsidised-access-to-tacrolimus-ointment 2026-10-01T11:00:01+10:00 https://pharmadispatch.com/news/fda-fast-tracks-telix-scan-that-could-spare-men-prostate-biopsies 2026-10-01T01:12:01+10:00 https://pharmadispatch.com/news/paradigm-biopharmaceuticals-enters-voluntary-administration-after-phase-3-setback 2026-10-01T02:46:01+10:00 https://pharmadispatch.com/news/vitrafy-takes-its-frozen-platelet-push-to-americas-midwest 2026-10-01T02:53:01+10:00 https://pharmadispatch.com/news/under-the-tgas-new-rules-a-safest-story-is-one-without-the-patient-experience 2026-10-02T11:00:01+10:00 https://pharmadispatch.com/news/sandoz-leads-pharmas-best-workplaces-as-rare-cancers-australia-makes-healthcare-list 2026-10-01T20:38:01+10:00 https://pharmadispatch.com/news/us-announces-formal-plan-that-benchmarks-pricing-against-australia-and-18-other-countries 2026-10-01T23:00:01+10:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-series-5-ep34 2026-10-02T22:19:01+10:00 https://pharmadispatch.com/news/csl-announces-investment-for-share-of-alentis-rare-kidney-and-liver-candidate 2026-10-06T12:00:01+11:00 https://pharmadispatch.com/news/tga-turns-to-national-security-surveillance-platform-to-police-therapeutic-goods-compliance 2026-10-06T12:00:01+11:00 https://pharmadispatch.com/news/young-nz-cancer-patients-to-get-funded-medicines-no-matter-where-they-are-treated 2026-10-06T12:00:01+11:00 https://pharmadispatch.com/news/tga-approves-roches-refillable-eye-implant-for-wet-macular-degeneration 2026-10-05T12:00:01+11:00 https://pharmadispatch.com/news/company-size-shapes-ceo-pay-trends-in-australian-health-care-and-biotechnology 2026-10-06T12:00:01+11:00 https://pharmadispatch.com/news/aft-reaffirms-profit-guidance-as-its-rd-pipeline-moves-toward-2029-launches 2026-10-07T12:00:01+11:00 https://pharmadispatch.com/news/every-serious-attempt-to-reform-pbs-pricing-runs-into-the-same-problem 2026-10-07T12:00:01+11:00 https://pharmadispatch.com/news/the-patient-who-knows-what-they-want-is-informed-and-not-a-danger 2026-10-07T12:00:01+11:00 https://pharmadispatch.com/news/csl-raises-us15-billion-from-us-bond-investors-to-refinance-debt 2026-10-07T20:52:01+11:00 https://pharmadispatch.com/news/pyc-to-present-early-polycystic-kidney-disease-trial-data-at-us-nephrology-conference 2026-10-07T21:13:01+11:00 https://pharmadispatch.com/news/syntara-drug-candidate-slows-motor-decline-in-people-at-high-risk-of-parkinsons 2026-10-07T21:24:01+11:00 https://pharmadispatch.com/news/life-scences-sector-warns-that-tax-overhaul-could-push-clinical-trials-offshore 2026-10-08T12:00:01+11:00 https://pharmadispatch.com/news/chinese-consensus-names-technegas-preferred-agent-for-pulmonary-embolism-imaging 2026-10-07T23:45:01+11:00 https://pharmadispatch.com/news/australia-cannot-afford-complacency-on-life-sciences-ausbiotech-warns-at-40 2026-10-08T12:00:01+11:00 https://pharmadispatch.com/news/australian-made-endoscope-cleaner-claims-top-design-honour 2026-10-08T03:41:01+11:00 https://pharmadispatch.com/news/moderna-and-csiro-launch-five-year-biosecurity-collaboration-focused-on-hendra-vaccine 2026-10-08T12:00:01+11:00 https://pharmadispatch.com/news/a-tale-of-two-systems-with-billions-shifting-to-the-private-market 2026-10-09T12:00:01+11:00 https://pharmadispatch.com/news/glp-1s-are-reshaping-the-australian-prescription-medicines-market 2026-10-09T12:00:01+11:00 https://pharmadispatch.com/news/phrma-goes-to-court-over-price-rule-that-uses-australia-as-a-benchmark 2026-10-09T12:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-week-in-review-series-5-ep35 2026-10-10T00:27:01+11:00 https://pharmadispatch.com/news/private-prescription-market-heads-towards-4-billion-as-pbs-spending-stalls 2026-10-12T12:00:01+11:00 https://pharmadispatch.com/news/the-full-set-of-numbers-tell-the-story-and-reveal-the-massive-funding-shortfall 2026-10-12T12:00:01+11:00 https://pharmadispatch.com/news/the-private-market-might-do-what-two-decades-of-reform-efforts-have-failed-to-deliver 2026-10-12T12:00:01+11:00 https://pharmadispatch.com/news/geneva-talks-put-australias-medicine-supply-worries-on-the-global-agenda 2026-10-13T12:00:01+11:00 https://pharmadispatch.com/news/the-pbs-stands-alone-as-the-only-major-health-and-disability-program-going-backwards 2026-10-13T12:00:01+11:00 https://pharmadispatch.com/news/racura-cleared-to-double-rc220-dose-in-lung-cancer-trial 2026-10-12T23:52:01+11:00 https://pharmadispatch.com/news/argent-biopharma-bets-on-inflammation-and-ageing-following-cannepil-deal 2026-10-12T23:58:01+11:00 https://pharmadispatch.com/news/australian-children-with-cancer-are-missing-out-on-trials-adults-can-access 2026-10-13T12:00:01+11:00 https://pharmadispatch.com/news/families-take-the-fight-for-faster-juvenile-arthritis-diagnosis-to-parliament-house 2026-10-13T12:00:01+11:00 https://pharmadispatch.com/news/until-the-law-changes-what-the-committee-is-asked-to-weigh-these-processes-will-deliver-nothing 2026-10-14T12:00:01+11:00 https://pharmadispatch.com/news/maximising-off-patent-medicines-why-the-pbs-needs-a-biosimilar-strategy 2026-10-14T12:00:01+11:00 https://pharmadispatch.com/news/priceline-pharmacy-puts-its-name-on-the-diamonds-as-netball-rides-record-growth 2026-10-14T12:00:01+11:00 https://pharmadispatch.com/news/peter-mac-taps-sydney-manufacturer-to-test-whether-its-solid-tumour-car-t-therapy-can-make-it-to 2026-10-14T12:00:01+11:00 https://pharmadispatch.com/news/brain-cancer-advocates-return-to-canberra-to-keep-that-ambition-alive 2026-10-15T11:00:01+11:00 https://pharmadispatch.com/news/the-medicines-gap-costing-australian-children-time-they-cant-get-back 2026-10-15T11:00:01+11:00 https://pharmadispatch.com/news/the-effort-to-change-an-institution-from-within-works-best-when-exit-is-possible 2026-10-15T11:00:01+11:00 https://pharmadispatch.com/news/ai-in-hta-survey-reveals-optimism-and-concern-over-a-potential-missed-opportunity 2026-10-16T12:00:01+11:00 https://pharmadispatch.com/news/englands-chief-scientific-officer-on-the-opportunity-for-australia-to-get-it-right-on-genomics 2026-10-15T21:20:01+11:00 https://pharmadispatch.com/news/tavneos-to-be-withdrawn-from-australia-as-csl-pulls-vasculitis-treatment 2026-10-16T12:00:01+11:00 https://pharmadispatch.com/news/biogen-anz-certified-a-great-place-to-work-for-a-fifth-time 2026-10-16T12:00:01+11:00 https://pharmadispatch.com/news/cancer-physicians-now-running-communication-skills-workshops-on-how-to-discuss-private-pay 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/if-your-doctor-prescribes-it-it-should-be-covered-pollster-recommends-as-the-key-message 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/global-headwinds-and-new-contenders-set-the-agenda-for-australias-biggest-week-in-biotech 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/pharmac-funding-wins-backing-across-new-zealands-political-divide 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/mixed-pbac-outcomes-for-multi-cancer-immunotherapy-listings 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/the-committee-that-rarely-fronts-is-called-to-answer-at-senate-estimates 2026-10-19T12:00:01+11:00 https://pharmadispatch.com/news/be-very-careful-about-arguing-for-more-pricing-legislation-because-you-might-just-get-it 2026-10-20T12:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-podcast-series-5-ep36 2026-10-19T23:37:01+11:00 https://pharmadispatch.com/news/an-argument-that-fails-based-on-its-own-research-findings 2026-10-20T12:00:01+11:00 https://pharmadispatch.com/news/novartis-boehringer-ingelheim-leaders-join-medicines-australia-board 2026-10-20T01:02:01+11:00 https://pharmadispatch.com/news/algorae-signs-two-part-deal-with-umedica-to-expand-australian-portfolio 2026-10-20T01:43:01+11:00 https://pharmadispatch.com/news/americas-rising-glp-1-curve-and-how-australia-is-following 2026-10-21T12:00:01+11:00 https://pharmadispatch.com/news/patient-groups-across-asia-pacific-push-for-a-say-on-medicine-prices 2026-10-21T12:00:01+11:00 https://pharmadispatch.com/news/if-anything-patient-groups-are-advocating-for-access-in-spite-of-minimal-funding 2026-10-21T12:00:01+11:00 https://pharmadispatch.com/news/chemist-warehouse-keeps-growing-as-sigma-sets-its-sights-on-oral-glp-1s 2026-10-21T21:48:01+11:00 https://pharmadispatch.com/news/quarterly-update-shows-telix-holds-course-for-a-us1-billion-year 2026-10-21T21:57:01+11:00 https://pharmadispatch.com/news/the-private-medicines-boom-has-mostly-passed-vaccines-by-for-now 2026-10-23T12:00:01+11:00 https://pharmadispatch.com/news/the-industry-walked-out-on-britain-and-what-it-cost-to-win-them-back 2026-10-22T12:00:01+11:00 https://pharmadispatch.com/news/biontech-opens-mrna-plant-putting-melbournes-north-on-the-biotech-map 2026-10-22T12:00:01+11:00 https://pharmadispatch.com/news/an-architect-of-the-first-industrycommonwealth-medicines-pact-to-lead-csl 2026-10-22T03:53:01+11:00 https://pharmadispatch.com/news/the-imperative-is-to-negotiate-with-the-fifth-year-of-the-agreement-in-mind 2026-10-23T12:00:01+11:00 https://pharmadispatch.com/news/arrotex-bets-on-recces-phase-3-gel-as-diabetic-foot-infections-get-harder-to-treat 2026-10-23T12:00:01+11:00 https://pharmadispatch.com/news/documents-reveal-that-net-pbs-spending-set-to-remain-on-life-support-to-the-end-of-decade 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/healths-multi-million-dollar-rebuild-of-cost-recovery-fees-is-happening-out-of-view 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/there-is-an-urgent-need-to-reconsider-the-question-of-pbs-sustainability 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/pbs-share-of-health-spending-on-track-to-halve-as-canberra-prepares-to-negotiate-with-industry 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/australia-leads-the-way-as-moderna-and-msd-take-personalised-cancer-vaccine-into-lung-cancer 2026-10-25T02:18:01+11:00 https://pharmadispatch.com/news/uti-and-contraception-care-comes-to-local-pharmacies-from-february 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-26-october 2026-10-26T12:00:01+11:00 https://pharmadispatch.com/news/access-delayed-the-stakes-for-the-industrys-next-agreements 2026-10-27T12:00:01+11:00 https://pharmadispatch.com/news/services-australia-annual-report-confirms-decline-in-prescription-volume 2026-10-27T12:00:01+11:00 https://pharmadispatch.com/news/csl-announces-new-chair-as-brian-mcnamee-prepares-to-bow-out 2026-10-27T00:53:01+11:00 https://pharmadispatch.com/news/the-stakes-are-very-high-on-access-in-a-contested-budget-environment 2026-10-28T12:00:01+11:00 https://pharmadispatch.com/news/company-rebates-fall-for-the-first-time-in-years-lifting-net-pbs-costs 2026-10-27T22:05:01+11:00 https://pharmadispatch.com/news/managing-an-agreement-negotiation-as-a-prisoner-of-circumstance 2026-10-28T12:00:01+11:00 https://pharmadispatch.com/news/msac-suggests-minister-skip-hta-and-make-policy-fix-to-ensure-access-to-this-technology 2026-10-28T12:00:01+11:00 https://pharmadispatch.com/news/lung-scarring-killing-11-australians-a-day-with-one-in-five-cases-traced-to-work 2026-10-28T12:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-takes-15-year-refund-limit-fight-to-the-senate-as-rd-tax-bill-lands 2026-10-28T12:00:01+11:00 https://pharmadispatch.com/news/astellas-bets-up-to-us134-billion-on-melbourne-startups-cancer-candidate 2026-10-28T21:48:01+11:00 https://pharmadispatch.com/news/rebates-and-net-spend-are-the-major-pbs-story-of-the-past-decade 2026-10-29T00:42:01+11:00 https://pharmadispatch.com/news/biotech-sector-warns-rd-tax-changes-could-drive-clinical-trials-offshore 2026-10-29T02:21:01+11:00 https://pharmadispatch.com/news/a-hearing-that-provided-more-evidence-of-the-need-for-meaningful-change 2026-10-29T12:00:01+11:00 https://pharmadispatch.com/news/if-only-these-patients-needed-a-spoodle-rather-than-a-medicine 2026-10-30T12:00:01+11:00 https://pharmadispatch.com/news/canberra-program-shows-young-women-where-a-future-in-health-could-take-them 2026-10-30T12:00:01+11:00 https://pharmadispatch.com/news/most-australians-want-pbs-medicine-prices-frozen-or-cut-poll-finds 2026-10-30T12:00:01+11:00 https://pharmadispatch.com/news/we-are-now-bridled-only-by-our-imagination-amgens-paul-burton-on-ai-and-medicines-hinge-moment 2026-11-02T12:00:01+11:00 https://pharmadispatch.com/news/australians-with-thyroid-eye-disease-gain-first-pbs-subsidised-treatment 2026-11-02T12:19:01+11:00 https://pharmadispatch.com/news/takedas-adcetris-gains-expanded-listing-for-first-line-treatment-of-advanced-hodgkin-lymphoma 2026-11-01T22:25:01+11:00 https://pharmadispatch.com/news/edwards-lifesciences-opens-new-sydney-head-office-as-heart-valve-disease-burden-grows 2026-11-01T22:31:01+11:00 https://pharmadispatch.com/news/medicines-industry-faces-tough-pbs-talks-but-will-it-be-the-most-challenging-ever 2026-11-03T12:00:01+11:00 https://pharmadispatch.com/news/report-finds-196-missing-medicines-and-billions-in-unreinvested-pbs-savings 2026-11-03T12:00:01+11:00 https://pharmadispatch.com/news/diabetes-scheme-registrations-fall-as-health-department-points-to-glp-1-use 2026-11-03T12:00:01+11:00 https://pharmadispatch.com/news/older-australians-given-three-weeks-to-have-their-say-on-in-home-aged-care-services-list 2026-11-03T12:00:01+11:00 https://pharmadispatch.com/news/is-the-reluctance-to-revisit-term-limits-because-they-are-such-an-obvious-change 2026-11-04T12:00:01+11:00 https://pharmadispatch.com/news/does-new-report-suggest-that-patient-voice-reforms-are-stalling 2026-11-04T12:00:01+11:00 https://pharmadispatch.com/news/sydney-summit-program-focused-on-the-reshaping-power-of-ai 2026-11-04T12:00:01+11:00 https://pharmadispatch.com/news/increased-accountability-can-be-the-only-response-to-expanding-authority 2026-11-05T12:00:01+11:00 https://pharmadispatch.com/news/vaccines-dominate-public-health-spending-but-prevention-investment-slips 2026-11-05T12:00:01+11:00 https://pharmadispatch.com/news/patients-and-clinicians-defend-ms-treatment-choice-during-review-stakeholder-meeting 2026-11-05T12:00:01+11:00 https://pharmadispatch.com/news/the-next-agreements-must-end-the-culture-of-enforced-silence 2026-11-06T12:00:01+11:00 https://pharmadispatch.com/news/the-lessons-we-can-take-from-robodebt-and-the-reserve-bank-reforms 2026-11-06T12:00:01+11:00 https://pharmadispatch.com/news/marie-guillet-joins-the-european-australian-business-council-board 2026-11-06T12:00:01+11:00 https://pharmadispatch.com/news/omico-names-laboratory-partners-to-expand-genomic-profiling-for-australians-with-cancer 2026-11-06T15:39:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-6-november 2026-11-06T23:03:01+11:00 https://pharmadispatch.com/news/pfizer-commissioned-polling-finds-strong-public-support-for-expanding-the-pbs 2026-11-09T12:00:01+11:00 https://pharmadispatch.com/news/pfizer-confirms-ben-fitzsimmons-as-australia-and-new-zealand-chief 2026-11-09T12:00:01+11:00 https://pharmadispatch.com/news/celairis-launches-with-plan-to-end-the-regions-place-at-the-rear-of-the-launch-queue 2026-11-09T12:00:01+11:00 https://pharmadispatch.com/news/coalition-edges-ahead-in-new-zealand-as-stephenson-returns-and-pharmac-pledges-await-the-special 2026-11-09T12:00:01+11:00 https://pharmadispatch.com/news/mayne-pharma-sells-salisbury-business-to-evaris-pharma-for-555-million 2026-11-10T12:00:01+11:00 https://pharmadispatch.com/news/dispatch-ai-index-finds-routine-ai-use-but-questions-over-governance 2026-11-10T12:00:01+11:00 https://pharmadispatch.com/news/bristol-myers-squibb-australia-riders-more-than-double-their-target-for-rare-cancers-australia 2026-11-10T12:00:01+11:00 https://pharmadispatch.com/news/ 2026-11-11T12:00:01+11:00 https://pharmadispatch.com/news/pbac-sets-out-its-expectations-for-ai-in-medicines-submissions 2026-11-11T12:00:01+11:00 https://pharmadispatch.com/news/the-negotiating-room-is-getting-smaller-as-officials-narrow-the-scope 2026-11-11T12:00:01+11:00 https://pharmadispatch.com/news/and-this-is-why-its-very-hard-not-to-be-cynical-in-this-system-because-this-committee-gets-to-se 2026-11-11T12:00:01+11:00 https://pharmadispatch.com/news/cartherics-takes-ovarian-cancer-cell-therapy-to-london-as-first-human-trial-nears 2026-11-11T22:52:01+11:00 https://pharmadispatch.com/news/they-can-try-but-institutions-cannot-outrun-the-disruptive-impact-of-technological-change 2026-11-12T12:00:01+11:00 https://pharmadispatch.com/news/patients-tired-of-polite-nods-turning-to-ai-to-force-canberras-hand 2026-11-12T12:00:01+11:00 https://pharmadispatch.com/news/bitool-unlocks-patient-voice-to-boost-patient-participation-in-the-evaluation-process 2026-11-12T12:00:01+11:00 https://pharmadispatch.com/news/there-is-no-need-for-ai-to-automate-the-care-out-of-healthcare-cohn-warns 2026-11-13T12:00:01+11:00 https://pharmadispatch.com/news/a-year-on-sanofi-now-asks-staff-to-explain-how-they-used-ai 2026-11-13T12:00:01+11:00 https://pharmadispatch.com/news/cochlears-global-government-affairs-chief-is-putting-ai-to-work 2026-11-13T12:00:01+11:00 https://pharmadispatch.com/news/longevity-life-sciences-welcomes-longer-tga-exclusivity-and-calls-for-existing-ingredients-to-be 2026-11-13T12:00:01+11:00 https://pharmadispatch.com/news/the-dispatched-week-in-review-podcast-13-november 2026-11-14T00:48:01+11:00